👪

Inheritance

1

Autosomal recessive ALX-related inheritance HP:0000007

The best-supported ALX-related subtypes are inherited in an autosomal recessive pattern, although ALX4 heterozygous relatives can show milder features in some families.

Autosomal recessive inheritance Expressivity: VARIABLE

Show evidence (1 reference)

PMID:19692347 SUPPORT Human Clinical

"We present two Turkish families with a new autosomal recessive frontofacial dysostosis syndrome characterized by total alopecia, a large skull defect, coronal craniosynostosis, hypertelorism, severely depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, callosal body agenesis and..."

Family-based human genetic evidence supports autosomal recessive inheritance for ALX4-related FND2.

◆

Subtypes

3

Frontonasal Dysplasia Type 1 / Frontorhiny MONDO:0007636

ALX3-related frontonasal dysplasia, also called frontorhiny, is an autosomal recessive subtype with hypertelorism, bifid nasal tip, abnormal philtrum and nares, and other midline nasal malformations.

Show evidence (1 reference)

DOI:10.1177/10556656211019621 SUPPORT Human Clinical

"A widened philtrum and prominent philtral columns are remarkable features of the ALX3-related FND1"

The genotype-informed clinical cohort identifies ALX3-related FND1 as a distinct frontonasal dysplasia subtype.

Frontonasal Dysplasia Type 2 MONDO:0013268

ALX4-related frontonasal dysplasia type 2 combines craniofacial malformation with alopecia, large parietal skull defects or foramina, genital anomalies or hypogonadism, and occasional corpus callosum anomalies.

Show evidence (1 reference)

PMID:19692347 SUPPORT Human Clinical

"We present two Turkish families with a new autosomal recessive frontofacial dysostosis syndrome characterized by total alopecia, a large skull defect, coronal craniosynostosis, hypertelorism, severely depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, callosal body agenesis and..."

The ALX4 family report supports the FND2 subtype's craniofacial, hair, genital, skull, and CNS feature cluster.

Frontonasal Dysplasia Type 3 MONDO:0013271

ALX1-related frontonasal dysplasia type 3 is a severe subtype with marked facial clefting, nasal malformation, and severe ocular anomalies such as microphthalmia or anophthalmia.

Show evidence (1 reference)

DOI:10.1177/10556656211019621 SUPPORT Human Clinical

"The ALX1-related FND3 phenotype is striking due to the involvement of the eyes in addition to the presence of hypertelorism, facial clefts, and nasal deformities."

The clinical cohort identifies ALX1-related FND3 as a severe subtype with ocular, clefting, hypertelorism, and nasal involvement.

⚙

Pathophysiology

3

ALX transcription factor disruption

ALX1, ALX3, and ALX4 encode aristaless-like homeobox transcription factors required for craniofacial development. Loss of ALX function disrupts midfacial patterning and produces subtype-specific frontonasal dysplasia phenotypes.

migratory cranial neural crest cell link

face development link ↓ DECREASED neural crest cell migration link ↓ DECREASED

Downstream

Cranial neural crest migration and survival defects ALX transcription factor defects impair the neural crest populations that pattern the frontonasal mesenchyme and related ocular structures.

BMP signaling dysregulation in neural crest cells ALX1 dysfunction alters BMP ligand balance in neural crest cells, linking transcription factor disruption to BMP-mediated migration defects.

Show evidence (1 reference)

PMID:27920634 SUPPORT Human Clinical

"Recent advances in the identification of the genetic basis of FNDs along with the analysis of developmental mechanisms impacted by these mutations have dramatically altered our understanding of this complex group of conditions."

This review frames frontonasal dysplasias as genetically heterogeneous developmental midline disorders.

Cranial neural crest migration and survival defects

ALX1-related disease models show increased apoptosis and impaired migration of neural crest cells and defective frontonasal mesenchyme identity. These early embryonic defects explain the midline facial clefts, nasal anomalies, and ocular malformations seen in severe ALX-related frontonasal dysplasia.

migratory cranial neural crest cell link

neural crest cell migration link ↓ DECREASED response to oxidative stress link

Show evidence (3 references)

PMID:32914578 SUPPORT In Vitro

"NCC derived from ALX1L165F/L165F iPSC were more sensitive to apoptosis, showed an elevated expression of several neural crest progenitor state markers, and exhibited impaired migration compared to wild-type controls."

Patient-derived iPSC neural crest cells directly support increased apoptosis and impaired migration as an ALX1-related mechanism.

PMID:32914578 SUPPORT Model Organism

"NCC migration was evaluated in vivo using lineage tracing in a zebrafish model, which revealed defective migration of the anterior NCC stream that contributes to the median portion of the anterior neurocranium, phenocopying the clinical presentation."

Zebrafish lineage tracing connects anterior cranial neural crest migration defects to the human midline craniofacial phenotype.

PMID:35127681 SUPPORT Model Organism

"Alx1 del/del embryos exhibited increased apoptosis of periocular mesenchyme and decreased expression of ocular developmental regulators Pitx2 and Lmxb1 in the periocular mesenchyme, followed by defective optic stalk morphogenesis."

Mouse ALX1 loss-of-function evidence supports apoptosis and regional patterning defects in craniofacial and ocular mesenchyme.

BMP signaling dysregulation in neural crest cells

ALX1-related neural crest cells show altered BMP ligand balance, with low BMP2 and high BMP9 in conditioned media. Rescue with soluble BMP2 or BMP9 antagonism supports BMP pathway imbalance as a mechanistic mediator of the neural crest migration defect.

migratory cranial neural crest cell link

BMP signaling pathway link

Show evidence (1 reference)

PMID:32914578 SUPPORT In Vitro

"Analysis of human NCC culture media revealed a change in the level of bone morphogenic proteins (BMP), with a low level of BMP2 and a high level of BMP9."

Patient-derived neural crest cell cultures demonstrate BMP signaling imbalance downstream of ALX1 dysfunction.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

10

Endocrine 1

Hypogonadism Hypogonadism (HP:0000135)

Show evidence (1 reference)

PMID:19692347 SUPPORT Human Clinical

"We present two Turkish families with a new autosomal recessive frontofacial dysostosis syndrome characterized by total alopecia, a large skull defect, coronal craniosynostosis, hypertelorism, severely depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, callosal body agenesis and..."

The ALX4 subtype report directly includes hypogonadism among the defining clinical features.

Eye 2

Hypertelorism frequent Hypertelorism (HP:0000316)

Show evidence (1 reference)

DOI:10.1177/10556656211019621 SUPPORT Human Clinical

"The ALX1-related FND3 phenotype is striking due to the involvement of the eyes in addition to the presence of hypertelorism, facial clefts, and nasal deformities."

The clinical cohort explicitly identifies hypertelorism as part of the ALX1-related FND3 phenotype.

Microphthalmia Microphthalmia (HP:0000568)

Show evidence (1 reference)

PMID:35142342 SUPPORT Model Organism

"ALX1 mutations in humans are linked to severe congenital anomalies of the facial skeleton (frontonasal dysplasia, FND) with malformation or absence of eyes and orbital contents (micro- and anophthalmia)."

The model-organism paper summarizes the human ALX1 ocular phenotype and then tests conserved mechanisms in zebrafish.

Head and Neck 1

Coronal craniosynostosis Coronal craniosynostosis (HP:0004440)

Show evidence (1 reference)

PMID:19692347 SUPPORT Human Clinical

"We present two Turkish families with a new autosomal recessive frontofacial dysostosis syndrome characterized by total alopecia, a large skull defect, coronal craniosynostosis, hypertelorism, severely depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, callosal body agenesis and..."

The ALX4 subtype report directly includes coronal craniosynostosis.

Integument 1

Alopecia Alopecia (HP:0001596)

Show evidence (1 reference)

PMID:19692347 SUPPORT Human Clinical

"We present two Turkish families with a new autosomal recessive frontofacial dysostosis syndrome characterized by total alopecia, a large skull defect, coronal craniosynostosis, hypertelorism, severely depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, callosal body agenesis and..."

The ALX4 subtype report directly includes total alopecia among the defining clinical features.

Nervous System 1

Agenesis of corpus callosum Agenesis of corpus callosum (HP:0001274)

Show evidence (1 reference)

PMID:19692347 SUPPORT Human Clinical

"severely depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, callosal body agenesis and mental retardation."

The ALX4 subtype report includes callosal body agenesis among affected individuals' features.

Other 4

Wide nasal bridge frequent Wide nasal bridge (HP:0000431)

Show evidence (1 reference)

PMID:19692347 SUPPORT Human Clinical

"severely depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, callosal body agenesis and mental retardation."

The ALX4 family report documents a severe nasal bridge abnormality in an autosomal recessive frontonasal dysplasia subtype.

Bifid nasal tip frequent Bifid nasal tip (HP:0000456)

Show evidence (1 reference)

PMID:19692347 SUPPORT Human Clinical

"severely depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, callosal body agenesis and mental retardation."

This exact abstract passage supports bifid nasal tip as part of the ALX4-related FND2 phenotype.

Facial cleft variable Tessier cleft (HP:0002006)

Show evidence (1 reference)

DOI:10.1177/10556656211019621 SUPPORT Human Clinical

"The ALX1-related FND3 phenotype is striking due to the involvement of the eyes in addition to the presence of hypertelorism, facial clefts, and nasal deformities."

The surgical cohort reports facial clefts as a defining ALX1-related FND3 feature.

Parietal foramina Parietal foramina (HP:0002697)

Show evidence (1 reference)

DOI:10.1177/10556656211019621 SUPPORT Human Clinical

"A widened philtrum and prominent philtral columns are remarkable features of the ALX3-related FND1, whereas the ALX4-related FND2 has more severe deformities: severe hypertelorism, brachycephaly, large parietal bone defects, broad nasal dorsum, and alopecia."

The ALX-related clinical cohort reports large parietal bone defects in ALX4-related FND2; HP:0002697 is the closest available term for parietal bone foramina/defects.

🧬

Genetic Associations

3

ALX1 (CAUSATIVE)

Show evidence (1 reference)

PMID:32914578 SUPPORT Human Clinical

"Genome sequencing and analysis identified a p.L165F missense variant in the homeodomain of the transcription factor ALX1 which was imputed to be pathogenic."

Human genome sequencing identifies an ALX1 homeodomain missense variant as pathogenic in affected subjects.

ALX3 (CAUSATIVE)

Show evidence (1 reference)

DOI:10.1177/10556656211019621 SUPPORT Human Clinical

"A widened philtrum and prominent philtral columns are remarkable features of the ALX3-related FND1, whereas the ALX4-related FND2 has more severe deformities: severe hypertelorism, brachycephaly, large parietal bone defects, broad nasal dorsum, and alopecia."

The genotype-informed cohort distinguishes ALX3-related FND1 from ALX4 and ALX1 subtypes.

ALX4 (CAUSATIVE)

Show evidence (1 reference)

PMID:19692347 SUPPORT Human Clinical

"Using homozygosity mapping, we mapped the entity to chromosome 11p11.2-q12.3 and subsequently identified a homozygous c.793C-->T nonsense mutation in the human ortholog of the mouse aristaless-like homeobox 4 (ALX4) gene."

Homozygosity mapping and variant identification establish ALX4 as a causal gene for this FND2 subtype.

💊

Treatments

1

Craniofacial reconstructive surgery

Action: craniofacial reconstructive surgery Ontology label: surgical procedure MAXO:0000004

Management is primarily surgical and supportive, with procedures selected by subtype-specific craniofacial anatomy. Reported interventions include facial bipartition, box osteotomies, eyelid coloboma repair, cleft lip and palate repair, nasal reconstruction, and fronto-orbital advancement.

Show evidence (1 reference)

DOI:10.1177/10556656211019621 SUPPORT Human Clinical

"Facial bipartition, box osteotomies, eyelid coloboma repair, cleft lip and palate repair, nasal reconstruction, and fronto-orbital advancement can be performed in ALX-related FNDs based on the characteristics of each subtype."

The largest cited ALX-related clinical cohort describes subtype-guided surgical management.

{ }

Source YAML

click to show

name: Frontonasal Dysplasia
creation_date: "2026-05-08T16:17:07Z"
updated_date: "2026-05-08T16:56:52Z"
category: Mendelian
description: >
  Frontonasal dysplasia is a heterogeneous group of congenital craniofacial
  midline disorders. Core features include hypertelorism, broad or bifid nasal
  structures, median facial clefting, and variable ocular, brain, skeletal,
  hair, and genital findings. Falcon deep research supported an ALX-centered
  root page with subtypes corresponding to ALX3-related frontorhiny/FND1,
  ALX4-related FND2, and ALX1-related FND3, plus additional related MONDO
  descendants that can be curated separately when prioritized.
disease_term:
  preferred_term: frontonasal dysplasia
  term:
    id: MONDO:0016643
    label: frontonasal dysplasia
parents:
- Dysostosis
has_subtypes:
- name: Frontorhiny
  display_name: Frontonasal Dysplasia Type 1 / Frontorhiny
  description: >
    ALX3-related frontonasal dysplasia, also called frontorhiny, is an
    autosomal recessive subtype with hypertelorism, bifid nasal tip, abnormal
    philtrum and nares, and other midline nasal malformations.
  subtype_term:
    preferred_term: frontorhiny
    term:
      id: MONDO:0007636
      label: frontorhiny
  evidence:
  - reference: DOI:10.1177/10556656211019621
    reference_title: "ALX-Related Frontonasal Dysplasias: Clinical Characteristics and Surgical Management"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A widened philtrum and prominent philtral columns are remarkable features
      of the ALX3-related FND1
    explanation: >
      The genotype-informed clinical cohort identifies ALX3-related FND1 as a
      distinct frontonasal dysplasia subtype.
- name: Frontonasal dysplasia with alopecia and genital anomaly
  display_name: Frontonasal Dysplasia Type 2
  description: >
    ALX4-related frontonasal dysplasia type 2 combines craniofacial
    malformation with alopecia, large parietal skull defects or foramina,
    genital anomalies or hypogonadism, and occasional corpus callosum
    anomalies.
  subtype_term:
    preferred_term: frontonasal dysplasia with alopecia and genital anomaly
    term:
      id: MONDO:0013268
      label: frontonasal dysplasia with alopecia and genital anomaly
  evidence:
  - reference: PMID:19692347
    reference_title: "ALX4 dysfunction disrupts craniofacial and epidermal development."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We present two Turkish families with a new autosomal recessive
      frontofacial dysostosis syndrome characterized by total alopecia, a large
      skull defect, coronal craniosynostosis, hypertelorism, severely depressed
      nasal bridge and ridge, bifid nasal tip, hypogonadism, callosal body
      agenesis and mental retardation.
    explanation: >
      The ALX4 family report supports the FND2 subtype's craniofacial, hair,
      genital, skull, and CNS feature cluster.
- name: Frontonasal dysplasia - severe microphthalmia - severe facial clefting syndrome
  display_name: Frontonasal Dysplasia Type 3
  description: >
    ALX1-related frontonasal dysplasia type 3 is a severe subtype with
    marked facial clefting, nasal malformation, and severe ocular anomalies
    such as microphthalmia or anophthalmia.
  subtype_term:
    preferred_term: frontonasal dysplasia type 3
    term:
      id: MONDO:0013271
      label: frontonasal dysplasia - severe microphthalmia - severe facial clefting syndrome
  evidence:
  - reference: DOI:10.1177/10556656211019621
    reference_title: "ALX-Related Frontonasal Dysplasias: Clinical Characteristics and Surgical Management"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The ALX1-related FND3 phenotype is striking due to the involvement of the
      eyes in addition to the presence of hypertelorism, facial clefts, and
      nasal deformities.
    explanation: >
      The clinical cohort identifies ALX1-related FND3 as a severe subtype with
      ocular, clefting, hypertelorism, and nasal involvement.
inheritance:
- name: Autosomal recessive ALX-related inheritance
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  expressivity: VARIABLE
  description: >
    The best-supported ALX-related subtypes are inherited in an autosomal
    recessive pattern, although ALX4 heterozygous relatives can show milder
    features in some families.
  evidence:
  - reference: PMID:19692347
    reference_title: "ALX4 dysfunction disrupts craniofacial and epidermal development."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We present two Turkish families with a new autosomal recessive
      frontofacial dysostosis syndrome characterized by total alopecia, a large
      skull defect, coronal craniosynostosis, hypertelorism, severely depressed
      nasal bridge and ridge, bifid nasal tip, hypogonadism, callosal body
      agenesis and mental retardation.
    explanation: >
      Family-based human genetic evidence supports autosomal recessive
      inheritance for ALX4-related FND2.
pathophysiology:
- name: ALX transcription factor disruption
  description: >
    ALX1, ALX3, and ALX4 encode aristaless-like homeobox transcription
    factors required for craniofacial development. Loss of ALX function
    disrupts midfacial patterning and produces subtype-specific frontonasal
    dysplasia phenotypes.
  cell_types:
  - preferred_term: migratory cranial neural crest cell
    term:
      id: CL:0000333
      label: migratory neural crest cell
  biological_processes:
  - preferred_term: face development
    term:
      id: GO:0060324
      label: face development
    modifier: DECREASED
  - preferred_term: neural crest cell migration
    term:
      id: GO:0001755
      label: neural crest cell migration
    modifier: DECREASED
  evidence:
  - reference: PMID:27920634
    reference_title: "Frontonasal Dysplasia: Towards an Understanding of Molecular and Developmental Aetiology."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Recent advances in the identification of the genetic basis of FNDs along
      with the analysis of developmental mechanisms impacted by these mutations
      have dramatically altered our understanding of this complex group of
      conditions.
    explanation: >
      This review frames frontonasal dysplasias as genetically heterogeneous
      developmental midline disorders.
  downstream:
  - target: Cranial neural crest migration and survival defects
    description: >
      ALX transcription factor defects impair the neural crest populations that
      pattern the frontonasal mesenchyme and related ocular structures.
    evidence:
    - reference: PMID:32914578
      reference_title: "ALX1-related frontonasal dysplasia results from defective neural crest cell development and migration."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        Taken together, these results demonstrate a mechanistic requirement of
        ALX1 in NCC development and migration.
      explanation: >
        This supports the causal edge from ALX disruption to defective neural
        crest development and migration.
  - target: BMP signaling dysregulation in neural crest cells
    description: >
      ALX1 dysfunction alters BMP ligand balance in neural crest cells, linking
      transcription factor disruption to BMP-mediated migration defects.
    evidence:
    - reference: PMID:32914578
      reference_title: "ALX1-related frontonasal dysplasia results from defective neural crest cell development and migration."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        Analysis of human NCC culture media revealed a change in the level of
        bone morphogenic proteins (BMP), with a low level of BMP2 and a high
        level of BMP9.
      explanation: >
        This supports the causal edge from ALX1 dysfunction to BMP signaling
        imbalance in neural crest cells.
- name: Cranial neural crest migration and survival defects
  description: >
    ALX1-related disease models show increased apoptosis and impaired
    migration of neural crest cells and defective frontonasal mesenchyme
    identity. These early embryonic defects explain the midline facial clefts,
    nasal anomalies, and ocular malformations seen in severe ALX-related
    frontonasal dysplasia.
  cell_types:
  - preferred_term: migratory cranial neural crest cell
    term:
      id: CL:0000333
      label: migratory neural crest cell
  biological_processes:
  - preferred_term: neural crest cell migration
    term:
      id: GO:0001755
      label: neural crest cell migration
    modifier: DECREASED
  - preferred_term: response to oxidative stress
    term:
      id: GO:0006979
      label: response to oxidative stress
  evidence:
  - reference: PMID:32914578
    reference_title: "ALX1-related frontonasal dysplasia results from defective neural crest cell development and migration."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      NCC derived from ALX1L165F/L165F iPSC were more sensitive to apoptosis,
      showed an elevated expression of several neural crest progenitor state
      markers, and exhibited impaired migration compared to wild-type controls.
    explanation: >
      Patient-derived iPSC neural crest cells directly support increased
      apoptosis and impaired migration as an ALX1-related mechanism.
  - reference: PMID:32914578
    reference_title: "ALX1-related frontonasal dysplasia results from defective neural crest cell development and migration."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      NCC migration was evaluated in vivo using lineage tracing in a zebrafish
      model, which revealed defective migration of the anterior NCC stream that
      contributes to the median portion of the anterior neurocranium,
      phenocopying the clinical presentation.
    explanation: >
      Zebrafish lineage tracing connects anterior cranial neural crest
      migration defects to the human midline craniofacial phenotype.
  - reference: PMID:35127681
    reference_title: "Alx1 Deficient Mice Recapitulate Craniofacial Phenotype and Reveal Developmental Basis of ALX1-Related Frontonasal Dysplasia."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Alx1 del/del embryos exhibited increased apoptosis of periocular
      mesenchyme and decreased expression of ocular developmental regulators
      Pitx2 and Lmxb1 in the periocular mesenchyme, followed by defective optic
      stalk morphogenesis.
    explanation: >
      Mouse ALX1 loss-of-function evidence supports apoptosis and regional
      patterning defects in craniofacial and ocular mesenchyme.
- name: BMP signaling dysregulation in neural crest cells
  description: >
    ALX1-related neural crest cells show altered BMP ligand balance, with low
    BMP2 and high BMP9 in conditioned media. Rescue with soluble BMP2 or BMP9
    antagonism supports BMP pathway imbalance as a mechanistic mediator of the
    neural crest migration defect.
  cell_types:
  - preferred_term: migratory cranial neural crest cell
    term:
      id: CL:0000333
      label: migratory neural crest cell
  biological_processes:
  - preferred_term: BMP signaling pathway
    term:
      id: GO:0030509
      label: BMP signaling pathway
  evidence:
  - reference: PMID:32914578
    reference_title: "ALX1-related frontonasal dysplasia results from defective neural crest cell development and migration."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Analysis of human NCC culture media revealed a change in the level of
      bone morphogenic proteins (BMP), with a low level of BMP2 and a high
      level of BMP9.
    explanation: >
      Patient-derived neural crest cell cultures demonstrate BMP signaling
      imbalance downstream of ALX1 dysfunction.
phenotypes:
- name: Hypertelorism
  description: >
    Widely spaced eyes are a core frontonasal dysplasia sign and are especially
    prominent in ALX-related subtypes.
  phenotype_term:
    preferred_term: Hypertelorism
    term:
      id: HP:0000316
      label: Hypertelorism
  frequency: frequent
  evidence:
  - reference: DOI:10.1177/10556656211019621
    reference_title: "ALX-Related Frontonasal Dysplasias: Clinical Characteristics and Surgical Management"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The ALX1-related FND3 phenotype is striking due to the involvement of the
      eyes in addition to the presence of hypertelorism, facial clefts, and
      nasal deformities.
    explanation: >
      The clinical cohort explicitly identifies hypertelorism as part of the
      ALX1-related FND3 phenotype.
- name: Wide nasal bridge
  description: >
    Broad nasal root or bridge morphology contributes to the characteristic
    frontonasal appearance and is prominent in ALX4-related FND2.
  phenotype_term:
    preferred_term: Wide nasal bridge
    term:
      id: HP:0000431
      label: Wide nasal bridge
  frequency: frequent
  evidence:
  - reference: PMID:19692347
    reference_title: "ALX4 dysfunction disrupts craniofacial and epidermal development."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      severely depressed nasal bridge and ridge, bifid nasal tip, hypogonadism,
      callosal body agenesis and mental retardation.
    explanation: >
      The ALX4 family report documents a severe nasal bridge abnormality in an
      autosomal recessive frontonasal dysplasia subtype.
- name: Bifid nasal tip
  description: >
    Splitting of the nasal tip is a recurrent nasal malformation across the
    ALX-related frontonasal dysplasia spectrum.
  phenotype_term:
    preferred_term: Bifid nasal tip
    term:
      id: HP:0000456
      label: Bifid nasal tip
  frequency: frequent
  evidence:
  - reference: PMID:19692347
    reference_title: "ALX4 dysfunction disrupts craniofacial and epidermal development."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      severely depressed nasal bridge and ridge, bifid nasal tip, hypogonadism,
      callosal body agenesis and mental retardation.
    explanation: >
      This exact abstract passage supports bifid nasal tip as part of the
      ALX4-related FND2 phenotype.
- name: Facial cleft
  description: >
    Median facial or orofacial clefting is a key structural manifestation,
    particularly in ALX1-related severe frontonasal dysplasia.
  phenotype_term:
    preferred_term: Tessier cleft
    term:
      id: HP:0002006
      label: Tessier cleft
  frequency: variable
  evidence:
  - reference: DOI:10.1177/10556656211019621
    reference_title: "ALX-Related Frontonasal Dysplasias: Clinical Characteristics and Surgical Management"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The ALX1-related FND3 phenotype is striking due to the involvement of the
      eyes in addition to the presence of hypertelorism, facial clefts, and
      nasal deformities.
    explanation: >
      The surgical cohort reports facial clefts as a defining ALX1-related FND3
      feature.
- name: Microphthalmia
  description: >
    Severe ocular malformation, including microphthalmia or anophthalmia, is
    characteristic of ALX1-related FND3.
  phenotype_term:
    preferred_term: Microphthalmia
    term:
      id: HP:0000568
      label: Microphthalmia
  subtype: Frontonasal dysplasia - severe microphthalmia - severe facial clefting syndrome
  evidence:
  - reference: PMID:35142342
    reference_title: "Zebrafish models of alx-linked frontonasal dysplasia reveal a role for Alx1 and Alx3 in the anterior segment and vasculature of the developing eye."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      ALX1 mutations in humans are linked to severe congenital anomalies of the
      facial skeleton (frontonasal dysplasia, FND) with malformation or absence
      of eyes and orbital contents (micro- and anophthalmia).
    explanation: >
      The model-organism paper summarizes the human ALX1 ocular phenotype and
      then tests conserved mechanisms in zebrafish.
- name: Agenesis of corpus callosum
  description: >
    Corpus callosum anomalies are variably reported, especially in ALX4-related
    frontonasal dysplasia with alopecia and genital anomaly.
  phenotype_term:
    preferred_term: Agenesis of corpus callosum
    term:
      id: HP:0001274
      label: Agenesis of corpus callosum
  subtype: Frontonasal dysplasia with alopecia and genital anomaly
  evidence:
  - reference: PMID:19692347
    reference_title: "ALX4 dysfunction disrupts craniofacial and epidermal development."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      severely depressed nasal bridge and ridge, bifid nasal tip, hypogonadism,
      callosal body agenesis and mental retardation.
    explanation: >
      The ALX4 subtype report includes callosal body agenesis among affected
      individuals' features.
- name: Alopecia
  description: >
    Total alopecia is a defining feature of ALX4-related frontonasal dysplasia
    with alopecia and genital anomaly.
  phenotype_term:
    preferred_term: Alopecia
    term:
      id: HP:0001596
      label: Alopecia
  subtype: Frontonasal dysplasia with alopecia and genital anomaly
  evidence:
  - reference: PMID:19692347
    reference_title: "ALX4 dysfunction disrupts craniofacial and epidermal development."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We present two Turkish families with a new autosomal recessive
      frontofacial dysostosis syndrome characterized by total alopecia, a large
      skull defect, coronal craniosynostosis, hypertelorism, severely depressed
      nasal bridge and ridge, bifid nasal tip, hypogonadism, callosal body
      agenesis and mental retardation.
    explanation: >
      The ALX4 subtype report directly includes total alopecia among the
      defining clinical features.
- name: Hypogonadism
  description: >
    Hypogonadism and genital anomalies are defining features of the ALX4-related
    FND2 subtype.
  phenotype_term:
    preferred_term: Hypogonadism
    term:
      id: HP:0000135
      label: Hypogonadism
  subtype: Frontonasal dysplasia with alopecia and genital anomaly
  evidence:
  - reference: PMID:19692347
    reference_title: "ALX4 dysfunction disrupts craniofacial and epidermal development."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We present two Turkish families with a new autosomal recessive
      frontofacial dysostosis syndrome characterized by total alopecia, a large
      skull defect, coronal craniosynostosis, hypertelorism, severely depressed
      nasal bridge and ridge, bifid nasal tip, hypogonadism, callosal body
      agenesis and mental retardation.
    explanation: >
      The ALX4 subtype report directly includes hypogonadism among the defining
      clinical features.
- name: Coronal craniosynostosis
  description: >
    Coronal craniosynostosis is reported in ALX4-related FND2.
  phenotype_term:
    preferred_term: Coronal craniosynostosis
    term:
      id: HP:0004440
      label: Coronal craniosynostosis
  subtype: Frontonasal dysplasia with alopecia and genital anomaly
  evidence:
  - reference: PMID:19692347
    reference_title: "ALX4 dysfunction disrupts craniofacial and epidermal development."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We present two Turkish families with a new autosomal recessive
      frontofacial dysostosis syndrome characterized by total alopecia, a large
      skull defect, coronal craniosynostosis, hypertelorism, severely depressed
      nasal bridge and ridge, bifid nasal tip, hypogonadism, callosal body
      agenesis and mental retardation.
    explanation: >
      The ALX4 subtype report directly includes coronal craniosynostosis.
- name: Parietal foramina
  description: >
    Large parietal bone defects are reported in ALX4-related FND2.
  phenotype_term:
    preferred_term: Parietal foramina
    term:
      id: HP:0002697
      label: Parietal foramina
  subtype: Frontonasal dysplasia with alopecia and genital anomaly
  evidence:
  - reference: DOI:10.1177/10556656211019621
    reference_title: "ALX-Related Frontonasal Dysplasias: Clinical Characteristics and Surgical Management"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A widened philtrum and prominent philtral columns are remarkable features
      of the ALX3-related FND1, whereas the ALX4-related FND2 has more severe
      deformities: severe hypertelorism, brachycephaly, large parietal bone
      defects, broad nasal dorsum, and alopecia.
    explanation: >
      The ALX-related clinical cohort reports large parietal bone defects in
      ALX4-related FND2; HP:0002697 is the closest available term for parietal
      bone foramina/defects.
genetic:
- name: ALX1
  gene_term:
    preferred_term: ALX1
    term:
      id: hgnc:1494
      label: ALX1
  association: CAUSATIVE
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: Frontonasal dysplasia - severe microphthalmia - severe facial clefting syndrome
  features: >
    Biallelic ALX1 dysfunction causes severe FND3 with neural crest migration
    defects, facial clefting, and severe ocular involvement.
  evidence:
  - reference: PMID:32914578
    reference_title: "ALX1-related frontonasal dysplasia results from defective neural crest cell development and migration."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Genome sequencing and analysis identified a p.L165F missense variant in
      the homeodomain of the transcription factor ALX1 which was imputed to be
      pathogenic.
    explanation: >
      Human genome sequencing identifies an ALX1 homeodomain missense variant
      as pathogenic in affected subjects.
- name: ALX3
  gene_term:
    preferred_term: ALX3
    term:
      id: hgnc:449
      label: ALX3
  association: CAUSATIVE
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: Frontorhiny
  features: >
    ALX3 is the causal gene for frontorhiny/FND1, a distinctive frontonasal
    dysplasia subtype with philtral and nasal malformations.
  evidence:
  - reference: DOI:10.1177/10556656211019621
    reference_title: "ALX-Related Frontonasal Dysplasias: Clinical Characteristics and Surgical Management"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A widened philtrum and prominent philtral columns are remarkable features
      of the ALX3-related FND1, whereas the ALX4-related FND2 has more severe
      deformities: severe hypertelorism, brachycephaly, large parietal bone
      defects, broad nasal dorsum, and alopecia.
    explanation: >
      The genotype-informed cohort distinguishes ALX3-related FND1 from ALX4
      and ALX1 subtypes.
- name: ALX4
  gene_term:
    preferred_term: ALX4
    term:
      id: hgnc:450
      label: ALX4
  association: CAUSATIVE
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  subtype: Frontonasal dysplasia with alopecia and genital anomaly
  features: >
    ALX4 loss of function causes FND2 with craniofacial, skull, epidermal/hair,
    genital, and occasional CNS involvement.
  evidence:
  - reference: PMID:19692347
    reference_title: "ALX4 dysfunction disrupts craniofacial and epidermal development."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Using homozygosity mapping, we mapped the entity to chromosome
      11p11.2-q12.3 and subsequently identified a homozygous c.793C-->T
      nonsense mutation in the human ortholog of the mouse aristaless-like
      homeobox 4 (ALX4) gene.
    explanation: >
      Homozygosity mapping and variant identification establish ALX4 as a
      causal gene for this FND2 subtype.
treatments:
- name: Craniofacial reconstructive surgery
  description: >
    Management is primarily surgical and supportive, with procedures selected
    by subtype-specific craniofacial anatomy. Reported interventions include
    facial bipartition, box osteotomies, eyelid coloboma repair, cleft lip and
    palate repair, nasal reconstruction, and fronto-orbital advancement.
  treatment_term:
    preferred_term: craniofacial reconstructive surgery
    term:
      id: MAXO:0000004
      label: surgical procedure
  evidence:
  - reference: DOI:10.1177/10556656211019621
    reference_title: "ALX-Related Frontonasal Dysplasias: Clinical Characteristics and Surgical Management"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Facial bipartition, box osteotomies, eyelid coloboma repair, cleft lip
      and palate repair, nasal reconstruction, and fronto-orbital advancement
      can be performed in ALX-related FNDs based on the characteristics of each
      subtype.
    explanation: >
      The largest cited ALX-related clinical cohort describes subtype-guided
      surgical management.
datasets: []

📚

References & Deep Research

Deep Research

1

Falcon ▸

Disease Characteristics Research Template

Edison Scientific Literature 38 citations 2026-05-08T12:34:17.504114

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on: 1. Key concepts and definitions with current understanding 2. Recent developments and latest research (prioritize 2023-2024 sources) 3. Current applications and real-world implementations 4. Expert opinions and analysis from authoritative sources 5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available. Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Disease Characteristics Research Template

Target Disease

Disease Name: Frontonasal Dysplasia
MONDO ID: (if available)
Category: Mendelian

Research Objectives

Please provide a comprehensive research report on Frontonasal Dysplasia covering all of the disease characteristics listed below. This report will be used to populate a disease knowledge base entry. Be thorough and cite primary literature (PMID preferred) for all claims.

For each section, suggested databases/resources are listed. These are the first places you should search for information on each topic.

1. Disease Information

Search first: OMIM, Orphanet, ICD-10/ICD-11, MeSH, PubMed

What is the disease? Provide a concise overview.
What are the key identifiers? (OMIM, Orphanet, ICD-10/ICD-11, MeSH, Mondo)
What are the common synonyms and alternative names?
Is the information derived from individual patients (e.g., EHR) or aggregated disease-level resources?

2. Etiology

Disease Causal Factors: What are the primary causes? (genetic, environmental, infectious, mechanistic)
Risk Factors:

Search first: PubMed, Cochrane Library, UpToDate, clinical guidelines, ClinVar, ClinGen, GWAS Catalog, PheGenI, CTD, CDC, WHO, epidemiological databases
Genetic risk factors (causal variants, susceptibility loci, modifier genes)
Environmental risk factors (toxins, lifestyle, occupational exposures, age, sex, family history)
Protective Factors:

Search first: PubMed, Cochrane Library, clinical trial databases, GWAS Catalog, gnomAD, WHO, CDC, nutrition databases
Genetic protective factors (protective variants, modifier alleles)
Environmental protective factors (diet, lifestyle, exposures that reduce risk)
Gene-Environment Interactions: How do genetic and environmental factors interact to influence disease?

Search first: CTD, PubMed, PheGenI, GxE databases

3. Phenotypes

Search first: HPO (Human Phenotype Ontology), OMIM, Orphanet, PubMed, clinicaltrials.gov, MedDRA, SNOMED CT, DECIPHER, LOINC

For each phenotype, provide: - Phenotype type: symptoms, clinical signs, physical manifestations, behavioral changes, or laboratory abnormalities

For symptoms/signs: HPO, OMIM, Orphanet, PubMed For behavioral changes: HPO, DSM, RDoC (Research Domain Criteria), PubMed For laboratory abnormalities: LOINC, SNOMED CT, LabTests Online, PubMed - Phenotype characteristics: Search first: OMIM, Orphanet, HPO, PubMed - Age of symptom onset (neonatal, childhood, adult-onset, late-onset) - Symptom severity (mild, moderate, severe, variable) - Symptom progression (stable, progressive, episodic, fluctuating) - Frequency among affected individuals (percentage or qualitative) - Quality of life impact: Effects on daily functioning and well-being (per-phenotype when possible) Search first: EQ-5D database, SF-36, WHO QOL databases, PubMed - Suggest HPO (Human Phenotype Ontology) terms for each phenotype

4. Genetic/Molecular Information

Causal Genes: Gene mutations or chromosomal abnormalities responsible for disease (gene symbols, OMIM IDs)

Search first: OMIM, ClinVar, HGMD, Ensembl, NCBI Gene
Pathogenic Variants:
Affected genes (gene symbols, HGNC IDs) > Search first: OMIM, NCBI Gene, Ensembl, HGNC, UniProt, GeneCards
Variant classification (pathogenic, likely pathogenic, VUS per ACMG/AMP guidelines) > Search first: ClinVar, ClinGen, ACMG/AMP guidelines, VarSome
Variant type/class (missense, frameshift, nonsense, splice-site, structural)
Allele frequency in population databases > Search first: gnomAD, 1000 Genomes, ExAC, TOPMed, dbSNP
Somatic vs germline origin > Search first: COSMIC (somatic), ClinVar, ICGC, TCGA
Functional consequences (loss of function, gain of function, dominant negative)
Modifier Genes: Genes that modify disease severity or expression
Epigenetic Information: DNA methylation, histone modifications, chromatin changes affecting disease

Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth
Chromosomal Abnormalities: Large-scale genetic changes (aneuploidy, translocations, inversions)

Search first: DECIPHER, ClinVar, ECARUCA, UCSC Genome Browser

5. Environmental Information

Environmental Factors: Non-genetic contributing factors (toxins, radiation, pollution, occupational exposure)

Search first: CTD (Comparative Toxicogenomics Database), TOXNET, PubMed, EPA databases
Lifestyle Factors: Behavioral factors (smoking, diet, exercise, alcohol consumption)

Search first: CDC databases, WHO, PubMed, NHANES
Infectious Agents: If applicable, pathogens causing or triggering disease (bacteria, viruses, fungi, parasites)

Search first: NCBI Taxonomy, ViPR, BV-BRC, MicrobeDB, GIDEON

6. Mechanism / Pathophysiology

Molecular Pathways: Specific signaling cascades or biochemical pathways involved (Wnt, MAPK, mTOR, PI3K-AKT, etc.)

Search first: KEGG, Reactome, WikiPathways, PathBank, BioCyc
Cellular Processes: Cell-level mechanisms (apoptosis, autophagy, cell cycle dysregulation, inflammation, etc.)

Search first: Gene Ontology (GO), Reactome, KEGG, PubMed
Protein Dysfunction: How protein structure or function is altered (misfolding, aggregation, loss of function, gain of function)

Search first: UniProt, PDB (Protein Data Bank), InterPro, Pfam, AlphaFold
Metabolic Changes: Alterations in metabolic processes (energy metabolism, lipid metabolism, amino acid metabolism)

Search first: KEGG, BioCyc, HMDB (Human Metabolome Database), BRENDA
Immune System Involvement: Role of immune response (autoimmunity, immunodeficiency, chronic inflammation)

Search first: ImmPort, Immunome Database, IEDB, Gene Ontology
Tissue Damage Mechanisms: How tissues/ are injured (oxidative stress, ischemia, fibrosis, necrosis)

Search first: PubMed, Gene Ontology, Reactome
Biochemical Abnormalities: Specific molecular defects (enzyme deficiencies, receptor dysfunction, ion channel defects)

Search first: BRENDA, UniProt, KEGG, OMIM, PubMed
Epigenetic Changes: DNA methylation, histone modifications affecting gene expression in disease

Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth
Molecular Profiling (if available):
Transcriptomics/gene expression changes > Search first: GEO (Gene Expression Omnibus), ArrayExpress, GTEx, Human Cell Atlas, SRA
Proteomics findings > Search first: PRIDE, ProteomeXchange, Human Protein Atlas, STRING, BioGRID
Metabolomics signatures > Search first: MetaboLights, Metabolomics Workbench, HMDB, METLIN
Lipidomics alterations > Search first: LIPID MAPS, SwissLipids, LipidHome, Metabolomics Workbench
Genomic structural features > Search first: UCSC Genome Browser, Ensembl, NCBI, dbVar, DGV
Advanced Technologies (if applicable):
Single-cell analysis findings (cell-type specific mechanisms, cellular heterogeneity) > Search first: Human Cell Atlas, Single Cell Portal, GEO, CELLxGENE
Spatial transcriptomics findings > Search first: GEO, Spatial Research, Vizgen, 10x Genomics data
Multi-omics integration results > Search first: TCGA, ICGC, cBioPortal, LinkedOmics, PubMed
Functional genomics screens (CRISPR, RNAi) > Search first: DepMap, GenomeRNAi, PubMed, BioGRID ORCS

For each mechanism, describe: - The causal chain from initial trigger to clinical manifestation - Which mechanisms are upstream vs downstream - What cell types and biological processes are involved - Suggest GO terms for biological processes and CL terms for cell types

7. Anatomical Structures Affected

Organ Level:
Primary organs directly affected
Secondary organ involvement (complications, secondary effects)
Body systems involved (cardiovascular, nervous, digestive, respiratory, endocrine, etc.)

Search first: Uberon, FMA (Foundational Model of Anatomy), OMIM, HPO, ICD-11, MeSH, SNOMED CT
Tissue and Cell Level:
Specific tissue types affected (epithelial, connective, muscle, nervous)
Specific cell populations targeted (with Cell Ontology terms)

Search first: Uberon, Human Protein Atlas, Cell Ontology, Human Cell Atlas, CellMarker, PanglaoDB
Subcellular Level:
Cellular compartments involved (mitochondria, nucleus, ER, lysosomes) (with GO Cellular Component terms)

Search first: Gene Ontology (Cellular Component), UniProt, Human Protein Atlas
Localization:
Specific anatomical sites (with UBERON terms) > Search first: FMA, Uberon, NeuroNames (for brain), SNOMED CT
Lateralization (unilateral, bilateral, asymmetric) > Search first: HPO, clinical literature, imaging databases

8. Temporal Development

Onset:
Typical age of onset (congenital, pediatric, adult, geriatric)
Onset pattern (acute, subacute, chronic, insidious)

Search first: OMIM, Orphanet, HPO, PubMed
Progression:
Disease stages (early, intermediate, advanced, end-stage) > Search first: Cancer Staging Manual (AJCC), WHO classifications, PubMed
Progression rate (rapid, slow, variable)
Disease course pattern (episodic, relapsing-remitting, progressive, stable)
Disease duration (self-limited, chronic lifelong)

Search first: Disease registries, longitudinal cohort databases, natural history studies, PubMed, Orphanet, OMIM
Patterns:
Remission patterns (spontaneous, treatment-induced) > Search first: Clinical trial databases, disease registries, PubMed
Critical periods (time windows of vulnerability or opportunity for intervention) > Search first: PubMed, developmental biology databases, clinical guidelines

9. Inheritance and Population

Epidemiology:
Prevalence (cases per 100,000 at given time)
Incidence (new cases per 100,000 per year)

Search first: Orphanet, CDC, WHO, GBD (Global Burden of Disease), national registries, SEER, disease registries
For Genetic Etiology:
Inheritance pattern (AD, AR, X-linked, mitochondrial, multifactorial, polygenic) > Search first: OMIM, Orphanet, ClinVar, GTR (Genetic Testing Registry)
Penetrance (complete, incomplete, age-dependent) > Search first: ClinVar, OMIM, PubMed, ClinGen
Expressivity (variable, consistent) > Search first: OMIM, ClinVar, PubMed
Genetic anticipation (increasing severity in successive generations) > Search first: OMIM, PubMed (especially for repeat expansion disorders)
Germline mosaicism > Search first: ClinVar, OMIM, genetic counseling literature, PubMed
Founder effects (population-specific mutations) > Search first: gnomAD, population genetics databases, PubMed
Consanguinity role > Search first: OMIM, population studies, genetic counseling resources
Carrier frequency > Search first: gnomAD, carrier screening databases, GeneReviews, GTR
Population Demographics:
Affected populations (ethnic or demographic groups with higher prevalence) > Search first: gnomAD, 1000 Genomes, PAGE Study, PubMed, population registries
Geographic distribution (endemic areas, regional variation) > Search first: WHO, CDC, GBD, Orphanet, geographic epidemiology databases
Geographic distribution of specific variants
Sex ratio (male:female) > Search first: Disease registries, OMIM, PubMed, epidemiological databases
Age distribution of affected individuals > Search first: CDC, disease registries, SEER, Orphanet

10. Diagnostics

Clinical Tests:
Laboratory tests (blood, urine, tissue chemistry, specific enzyme assays) > Search first: LOINC, LabTests Online, PubMed
Biomarkers (proteins, metabolites, genetic markers, circulating biomarkers) > Search first: FDA Biomarker List, BEST (Biomarkers, EndpointS, and other Tools), PubMed
Imaging studies (X-ray, CT, MRI, PET, ultrasound) > Search first: RadLex, DICOM, Radiopaedia, imaging databases
Functional tests (pulmonary function, cardiac stress tests) > Search first: LOINC, clinical guidelines, PubMed
Electrophysiology (EEG, EMG, ECG, nerve conduction studies) > Search first: LOINC, clinical neurophysiology databases, PubMed
Biopsy findings (histopathology, immunohistochemistry) > Search first: SNOMED CT, College of American Pathologists resources, PubMed
Pathology findings (microscopic examination) > Search first: SNOMED CT, Digital Pathology databases, PubMed
Genetic Testing:

Search first: GTR (Genetic Testing Registry), GeneReviews, ClinGen
Overview of recommended genetic testing approach
Whole genome sequencing (WGS) utility > Search first: GTR, ClinVar, GEL (Genomics England), gnomAD
Whole exome sequencing (WES) utility > Search first: GTR, ClinVar, OMIM, GeneMatcher
Gene panels (which panels, which genes) > Search first: GTR, ClinVar, laboratory-specific databases
Single gene testing > Search first: GTR, ClinVar, OMIM, GeneReviews
Chromosomal microarray (CMA) > Search first: DECIPHER, ClinVar, dbVar, ECARUCA
Karyotyping > Search first: Chromosome Abnormality Database, ClinVar, cytogenetics resources
FISH > Search first: ClinVar, cytogenetics databases, PubMed
Mitochondrial DNA testing > Search first: MITOMAP, MSeqDR, ClinVar, GTR
Repeat expansion testing > Search first: GTR, ClinVar, repeat expansion databases, PubMed
Omics-Based Diagnostics (if applicable):
RNA sequencing / transcriptomics > Search first: GEO, ArrayExpress, GTEx, RNA-seq databases
Proteomics > Search first: PRIDE, ProteomeXchange, FDA Biomarker database
Metabolomics > Search first: MetaboLights, Metabolomics Workbench, HMDB
Epigenomics > Search first: GEO, ENCODE, Roadmap Epigenomics, MethBase
Liquid biopsy > Search first: COSMIC, ClinVar, liquid biopsy databases, PubMed
Clinical Criteria:
Standardized diagnostic criteria (DSM, ICD, society guidelines) > Search first: DSM-5, ICD-11, clinical society guidelines, UpToDate
Differential diagnosis (other conditions to rule out, with distinguishing features) > Search first: DynaMed, UpToDate, clinical decision support systems
Screening:
Screening methods for asymptomatic individuals (newborn screening, carrier screening, cascade screening) > Search first: ACMG recommendations, CDC newborn screening, GTR

11. Outcome/Prognosis

Survival and Mortality:
Survival rate (5-year, 10-year, overall) > Search first: SEER, cancer registries, disease-specific registries, PubMed
Life expectancy (with and without treatment if applicable) > Search first: Orphanet, disease registries, actuarial databases, PubMed
Mortality rate > Search first: CDC, WHO, GBD, national mortality databases
Disease-specific mortality (deaths directly attributable to disease) > Search first: Disease registries, CDC Wonder, GBD, PubMed
Morbidity and Function:
Morbidity (disease-related disability and health impacts) > Search first: GBD, WHO, disability databases, PubMed
Disability outcomes (long-term functional impairments) > Search first: ICF (International Classification of Functioning), disability registries
Quality of life measures (EQ-5D, SF-36, PROMIS, disease-specific tools) > Search first: EQ-5D database, SF-36, PROMIS, PubMed
Disease Course:
Complications (secondary problems: infections, organ failure, etc.) > Search first: ICD codes, disease registries, clinical databases, PubMed
Recovery potential (likelihood and extent of recovery, with vs without treatment) > Search first: Natural history studies, rehabilitation databases, PubMed
Prediction:
Prognostic factors (age, disease severity, biomarkers, treatment response) > Search first: Prognostic models databases, clinical calculators, PubMed
Prognostic biomarkers (molecular markers predicting disease course) > Search first: FDA Biomarker database, PubMed, cancer prognostic databases

12. Treatment

Pharmacotherapy:
Pharmacological treatments (drug names, drug classes, mechanisms of action) > Search first: DrugBank, RxNorm, ATC classification, DailyMed, FDA databases
Pharmacogenomics (how genetic variants affect drug metabolism, efficacy, toxicity) > Search first: PharmGKB, CPIC (Clinical Pharmacogenetics), FDA Table of PGx Biomarkers
Advanced Therapeutics:
Gene therapy (viral vectors, CRISPR, gene replacement, gene editing) > Search first: ClinicalTrials.gov, FDA gene therapy database, ASGCT resources
Cell therapy (stem cell transplant, CAR-T, cellular therapeutics) > Search first: ClinicalTrials.gov, FDA cell therapy database, FACT standards
RNA-based therapies (ASOs, siRNA, mRNA therapies) > Search first: ClinicalTrials.gov, FDA approvals, PubMed
Targeted therapies (treatments directed at specific molecular targets) > Search first: My Cancer Genome, OncoKB, ClinicalTrials.gov, FDA approvals
Immunotherapies (checkpoint inhibitors, monoclonal antibodies) > Search first: Cancer Immunotherapy Database, FDA approvals, ClinicalTrials.gov
Surgical and Interventional:
Surgical interventions (types of surgery, timing, outcomes) > Search first: CPT codes, surgical registries, clinical guidelines, PubMed
Supportive and Rehabilitative:
Supportive care (symptom management, pain control, nutrition) > Search first: Clinical guidelines, Cochrane Library, PubMed
Rehabilitation (physical therapy, occupational therapy, speech therapy) > Search first: Rehabilitation medicine databases, clinical guidelines, PubMed
Experimental:
Experimental treatments in clinical trials (with NCT identifiers if available) > Search first: ClinicalTrials.gov, EU Clinical Trials Register, WHO ICTRP
Treatment Outcomes:
Treatment response rates > Search first: Clinical trial databases, FDA reviews, systematic reviews, PubMed
Side effects and adverse events > Search first: FDA Adverse Event Reporting System (FAERS), MedWatch, PubMed
Treatment Strategy:
Treatment algorithms (clinical pathways, decision trees) > Search first: Clinical practice guidelines, NCCN Guidelines, UpToDate
Combination therapies > Search first: ClinicalTrials.gov, treatment guidelines, PubMed
Personalized medicine approaches (genotype-guided treatment) > Search first: My Cancer Genome, CIViC, PharmGKB, precision medicine databases

For each treatment, suggest MAXO (Medical Action Ontology) terms where applicable.

13. Prevention

Prevention Levels:
Primary prevention (preventing disease occurrence: vaccination, risk factor modification) > Search first: CDC, WHO, USPSTF recommendations, Cochrane Library
Secondary prevention (early detection and treatment: screening programs, early intervention) > Search first: USPSTF, CDC screening guidelines, WHO
Tertiary prevention (preventing complications in those with disease) > Search first: Clinical guidelines, disease management protocols, PubMed
Immunization: Vaccine strategies (if applicable)

Search first: CDC vaccine schedules, WHO immunization, FDA vaccine database
Screening and Early Detection:
Screening programs (population-based: newborn screening, cancer screening) > Search first: CDC screening programs, USPSTF, cancer screening databases
Genetic screening (carrier screening, preimplantation genetic diagnosis, prenatal testing) > Search first: ACMG recommendations, ACOG guidelines, GTR
Risk stratification (identifying high-risk individuals for targeted prevention) > Search first: Risk prediction models, clinical calculators, PubMed
Behavioral Interventions: Lifestyle modifications to reduce risk

Search first: CDC, WHO, behavioral intervention databases, Cochrane Library
Counseling: Genetic counseling (risk assessment, family planning guidance)

Search first: NSGC resources, ACMG guidelines, GeneReviews
Public Health:
Public health interventions (sanitation, vector control, health education) > Search first: CDC, WHO, public health databases, PubMed
Environmental interventions (reducing environmental risk factors) > Search first: EPA databases, WHO environmental health, PubMed
Prophylaxis: Preventive medications or procedures

Search first: Clinical guidelines, FDA approvals, PubMed

14. Other Species / Natural Disease

Taxonomy: Species affected (with NCBI Taxon identifiers)

Search first: NCBI Taxonomy
Breed: Specific breeds affected (with VBO identifiers if applicable)

Search first: VBO (Vertebrate Breed Ontology)
Gene: Orthologous genes in other species (with NCBI Gene IDs)

Search first: NCBI Gene
Natural Disease:
Naturally occurring disease in other species (companion animals, wildlife) > Search first: OMIA (Online Mendelian Inheritance in Animals), VetCompass, PubMed
Veterinary relevance and importance in animal health > Search first: OMIA, veterinary databases, PubMed
Comparative Biology:
Comparative pathology (similarities and differences across species) > Search first: OMIA, comparative pathology databases, PubMed
Evolutionary conservation of disease mechanisms > Search first: HomoloGene, OrthoMCL, Alliance of Genome Resources
Transmission (if applicable):
Zoonotic potential > Search first: CDC zoonotic diseases, WHO zoonoses, GIDEON
Cross-species susceptibility > Search first: NCBI Taxonomy, veterinary databases, PubMed

15. Model Organisms

Model Types:
Model organism type (mammalian, invertebrate, cellular, in vitro) > Search first: Alliance of Genome Resources, model organism databases
Specific model systems (mouse, rat, zebrafish, Drosophila, C. elegans, yeast, cell lines, organoids, iPSCs) > Search first: MGI, RGD, ZFIN, FlyBase, WormBase, SGD, ATCC, Cellosaurus
Induced models (drug treatment, surgical intervention, environmental manipulation) > Search first: MGI, model organism databases, PubMed
Genetic Models:
Types available (knockout, knock-in, transgenic, conditional, humanized) > Search first: MGI, IMPC, KOMP, EuMMCR, IMSR
Model Characteristics:
Phenotype recapitulation (how well model reproduces human disease features) > Search first: Model organism databases, comparative studies, PubMed
Model limitations (aspects of human disease not captured) > Search first: Model organism databases, PubMed, review articles
Applications:
Research applications (what aspects of disease can be studied) > Search first: Model organism databases, PubMed
Resources:
Model databases > Search first: MGI, RGD, ZFIN, FlyBase, WormBase, IMSR, EMMA, MMRRC

Citation Requirements

Cite primary literature (PMID preferred) for all mechanistic and clinical claims
Prioritize recent reviews and landmark papers
Include direct quotes from abstracts where possible to support key statements
Distinguish evidence source types: human clinical, model organism, in vitro, computational

Output Format

Structure your response as a comprehensive narrative organized by the sections above. For each section, provide: - Factual content with specific details (numbers, percentages, gene names, variant nomenclature) - Ontology term suggestions (HPO, GO, CL, UBERON, CHEBI, MAXO, MONDO) where applicable - Evidence citations with PMIDs - Direct quotes from abstracts to support key claims - Clear indication when information is not available or not applicable for this disease

This report will be used to populate a disease knowledge base entry with: - Pathophysiology descriptions with causal chains - Gene/protein annotations (HGNC, GO terms) - Phenotype associations (HP terms) with frequencies - Cell type involvement (CL terms) - Anatomical locations (UBERON terms) - Chemical entities (CHEBI terms) - Treatment annotations (MAXO terms) - Evidence items with PMIDs and exact abstract quotes - Epidemiology, prognosis, diagnostic, and prevention information - Animal model descriptions with phenotype recapitulation details

Frontonasal Dysplasia (FND): Comprehensive Disease Characteristics Research Report (Mendelian)

Executive summary

Frontonasal dysplasia (FND) is a rare, congenital craniofacial midline malformation spectrum attributed to abnormal development of the frontonasal process and associated cranial neural crest–derived tissues, producing variable combinations of ocular hypertelorism, nasal clefting/bifidity, and midline facial clefting; in some patients, ocular and brain malformations co-occur. (guo2024prenataldiagnosisof pages 1-3, farlie2016frontonasaldysplasiatowards pages 1-2)

The most evidence-supported Mendelian causes in the retrieved literature are (i) autosomal recessive ALX-family disorders (ALX1, ALX3, ALX4; often labeled FND3/FND1/FND2 respectively) and (ii) X-linked EFNB1-related craniofrontonasal syndrome (CFNS), a closely related frontonasal/craniosynostosis disorder that can overlap clinically but has distinct ectodermal and craniosynostosis features and a characteristic sex-severity paradox. (vargel2022alxrelatedfrontonasaldysplasias pages 1-2, twigg2009frontorhinyadistinctive pages 2-3, kayserili2009alx4dysfunctiondisrupts pages 2-3, farlie2016frontonasaldysplasiatowards pages 4-5)

Recent (2023–2024) literature emphasizes (a) improved prenatal recognition using 3D ultrasound and collation of prenatal-case phenotypic frequencies, (b) new/ongoing delineation of ALX4-related FND2 via case reports, and (c) mechanistic advances connecting upstream neural crest transcriptional regulators (TFAP2) to an ALX genetic pathway essential for midfacial development. (guo2024prenataldiagnosisof pages 1-3, goswami2024ararehomozygous pages 1-2, nguyen2024tfap2paralogsregulate pages 1-3)

1. Disease information

1.1 What is the disease?

FND is a rare congenital anomaly caused by abnormal/insufficient development of the frontonasal process with a broad phenotypic spectrum affecting the eyes, nose, and forehead. (guo2024prenataldiagnosisof pages 1-3)

Direct abstract quote (prenatal context): Guo et al. state: “Only approximately 10 cases of prenatally diagnosed nonsyndromic FND have been reported in the past 30 years.” (BMC Pregnancy and Childbirth; 2024-06; https://doi.org/10.1186/s12884-024-06619-4) (guo2024prenataldiagnosisof pages 1-3)

1.2 Key identifiers

Evidence in the retrieved sources supports the following OMIM/MIM identifiers: - FND (overall): MIM 136760 (vargel2022alxrelatedfrontonasaldysplasias pages 1-2, vargel2022alxrelatedfrontonasaldysplasias pages 2-3) - FND1 (ALX3-related / frontorhiny phenotype in some literature): MIM 136760 as used in a genotype-based surgical cohort (vargel2022alxrelatedfrontonasaldysplasias pages 2-3) - FND2 (ALX4-related): MIM 613451 (vargel2022alxrelatedfrontonasaldysplasias pages 2-3) - FND3 (ALX1-related): MIM 613456 (vargel2022alxrelatedfrontonasaldysplasias pages 2-3)

Not available from retrieved evidence: MONDO ID, Orphanet ID, MeSH ID, ICD-10/ICD-11 codes were not found in the retrieved full texts and therefore cannot be asserted here.

1.3 Common synonyms / alternative names

Guo et al. explicitly list the following synonyms for FND: - Median cleft face syndrome - Frontonasal syndrome - Frontonasal dysostosis (guo2024prenataldiagnosisof pages 1-3)

1.4 Evidence sources (patient-level vs aggregated)

Most actionable information in the retrieved corpus derives from: - Individual case reports and families (e.g., ALX4 case report, prenatal FND case report) (goswami2024ararehomozygous pages 1-2, guo2024prenataldiagnosisof pages 1-3) - Aggregated cohorts/case series (e.g., an 89-patient single-institution clinical/surgical series; prenatal-case literature aggregation) (vargel2022alxrelatedfrontonasaldysplasias pages 2-3, guo2024prenataldiagnosisof pages 3-5) - Mechanistic studies using iPSCs and animal models (zebrafish, mouse) to connect genotype to cellular phenotypes (pini2020alx1‐ pages 1-2, iyyanar2022alx1deficientmice pages 1-2, yoon2022zebrafishmodelsof pages 1-2)

2. Etiology

2.1 Disease causal factors

2.1.1 Genetic causes (major, evidence-supported)

1) ALX-related FND subtypes (Mendelian, primarily autosomal recessive) - FND1 (ALX3), FND2 (ALX4), FND3 (ALX1) are described as distinct genotypic categories in a genotype-informed surgical cohort. (vargel2022alxrelatedfrontonasaldysplasias pages 2-3) - These genes encode homeobox transcription factors crucial for craniofacial development and neural-crest-derived mesenchyme patterning. (pini2020alx1‐ pages 1-2, iyyanar2022alx1deficientmice pages 1-2)

2) EFNB1-related craniofrontonasal syndrome (CFNS) (X-linked) - EFNB1 mutations cause CFNS, which features frontonasal anomalies plus craniosynostosis and ectodermal findings; females typically have more severe manifestations than males due to mosaic “cellular interference.” (farlie2016frontonasaldysplasiatowards pages 4-5, pachajoa2023casereportcraniofrontonasal pages 1-3)

2.1.2 Developmental mechanism as etiology (frontonasal process biology)

FND is framed as arising from disruption of the frontonasal process, which contains ectoderm over neural-crest-derived mesenchyme and is influenced by forebrain neuroepithelium—providing a developmental rationale for co-occurring craniofacial and CNS anomalies. (farlie2016frontonasaldysplasiatowards pages 1-2)

2.2 Risk factors

2.2.1 Genetic risk factors

ALX3 (FND1/frontorhiny): biallelic/homozygous pathogenic variants are associated with affected phenotypes, while heterozygous relatives often lack facial manifestations in reported families. (twigg2009frontorhinyadistinctive pages 2-3)
ALX4 (FND2): homozygous variants in consanguineous families are strongly associated with FND2; heterozygotes in some families can show milder features. (kayserili2009alx4dysfunctiondisrupts pages 2-3, hussain2020anovelmissense pages 1-2)
ALX1 (FND3): pathogenic variants are associated with severe craniofacial and ocular malformations and mechanistic neural-crest defects. (pini2020alx1‐ pages 1-2)
EFNB1 (CFNS): heterozygous females are typically more severely affected than hemizygous males. (farlie2016frontonasaldysplasiatowards pages 4-5, pachajoa2023casereportcraniofrontonasal pages 1-3)

2.2.2 Environmental risk factors / teratogens

A gene–environment interaction relevant to midfacial malformations is suggested by zebrafish: ethanol exposure increased penetrance of facial/ocular malformations in alx1 mutants, consistent with a protective role for alx genes against ethanol-induced oxidative stress in neural crest lineages. (yoon2022zebrafishmodelsof pages 1-2)

2.3 Protective factors

In zebrafish models, alx3 upregulation in alx1 mutants is interpreted as compensatory/transcriptional adaptation that can reduce penetrance in single mutants relative to double mutants. (yoon2022zebrafishmodelsof pages 1-2)

2.4 Gene–environment interactions

Ethanol–alx1 interaction (model organism evidence): ethanol exposure increases malformation penetrance in alx1 mutants; oxidative stress response is implicated as a mechanistic target. (yoon2022zebrafishmodelsof pages 1-2)

3. Phenotypes

3.1 Core clinical phenotype (FND)

Common/defining findings include: - True ocular hypertelorism (HPO: HP:0000316) (farlie2016frontonasaldysplasiatowards pages 1-2) - Broad nasal bridge/root (HPO: HP:0000431) - Bifid nasal tip / nasal bifidity (HPO: HP:0005931) (guo2024prenataldiagnosisof pages 1-3) - Median facial cleft (HPO: HP:0000280) (guo2024prenataldiagnosisof pages 1-3) - Widow’s peak or V-shaped hairline (HPO: HP:0000349 as “widow’s peak”) (guo2024prenataldiagnosisof pages 1-3)

Onset: congenital (prenatal/neonatal), by definition of a congenital malformation spectrum. (guo2024prenataldiagnosisof pages 1-3)

3.2 Diagnostic criteria (clinical definition)

Farlie et al. present historically derived defining features and note that a diagnosis generally requires at least two defining features (e.g., hypertelorism, broad nasal root, nasal tip deficiency/bifidity, median facial cleft, alar clefting, widow’s peak). (farlie2016frontonasaldysplasiatowards pages 1-2)

3.3 Subtype-specific phenotype patterns (genotype–phenotype)

From a genotype-informed cohort: - ALX1 / FND3: ocular involvement is striking; severe microphthalmia/anophthalmia, facial clefts, nasal deformities. (vargel2022alxrelatedfrontonasaldysplasias pages 1-2, vargel2022alxrelatedfrontonasaldysplasias pages 2-3) - ALX3 / FND1: widened philtrum and prominent philtral columns/swellings; bifid nasal tip and hypoplastic columella. (vargel2022alxrelatedfrontonasaldysplasias pages 1-2, vargel2022alxrelatedfrontonasaldysplasias pages 2-3) - ALX4 / FND2: severe hypertelorism, brachycephaly, large parietal bone defects, broad nasal dorsum/bridge, alopecia; may include genital and CNS anomalies. (vargel2022alxrelatedfrontonasaldysplasias pages 1-2, farlie2016frontonasaldysplasiatowards pages 4-5, goswami2024ararehomozygous pages 1-2)

3.4 Prenatal phenotype frequencies (recent quantitative data; 2024)

Guo et al. summarize prenatally diagnosed nonsyndromic cases (literature plus their case): - Hypertelorism: 9/9 - Deformed nose: 8/9 - Cleft lip/palate: 8/9 - Hypoplasia of other craniofacial bones: 6/9 - Abnormal ears: 2/9 They also note CNS malformations were the most commonly observed features in this prenatal subset (examples include corpus callosum agenesis/hypoplasia, cephalocele, hydrocephalus). (guo2024prenataldiagnosisof pages 3-5)

3.5 Quality of life impact

Direct quantitative quality-of-life instruments (EQ-5D/SF-36/PROMIS) were not present in the retrieved evidence. Clinical/surgical literature emphasizes psychosocial and functional motivations for early and staged craniofacial reconstruction, implying substantial potential impact on social function and adaptation. (vargel2022alxrelatedfrontonasaldysplasias pages 5-6)

4. Genetic / molecular information

4.1 Causal genes (major)

ALX1 (FND3) (vargel2022alxrelatedfrontonasaldysplasias pages 2-3, pini2020alx1‐ pages 1-2)
ALX3 (FND1 / frontorhiny) (twigg2009frontorhinyadistinctive pages 2-3)
ALX4 (FND2) (kayserili2009alx4dysfunctiondisrupts pages 2-3, hussain2020anovelmissense pages 1-2)
EFNB1 (craniofrontonasal syndrome) (farlie2016frontonasaldysplasiatowards pages 4-5, pachajoa2023casereportcraniofrontonasal pages 1-3)

4.2 Pathogenic variants (examples with variant class)

ALX3 (frontorhiny / FND1)

Twigg et al. identify “four different mutations of ALX3 (all homozygous)” including: - Splice-acceptor: c.595-2A>T - Missense: c.608A>G (p.Asn203Ser) - Homeodomain missense: c.502C>G (p.Leu168Val) They report evidence consistent with autosomal recessive inheritance (heterozygous relatives without facial manifestations in their cohort). (twigg2009frontorhinyadistinctive pages 2-3)

Ullah et al. report a homozygous nonsense variant: - c.604C>T (p.Gln202*), predicted LoF via NMD/truncation. (ullah2018exomesequencingrevealed pages 3-4)

ALX4 (FND2)

Kayserili et al. report a homozygous nonsense ALX4 variant in consanguineous families (HGVS details not present in the retrieved excerpt) causing craniofacial and epidermal development disruption (including alopecia). (kayserili2009alx4dysfunctiondisrupts pages 2-3)
Hussain et al. report NM_021926.4:c.652C>T (p.Arg218Trp), homozygous in severely affected individuals and associated with milder phenotypes in heterozygous carriers in the same family. (hussain2020anovelmissense pages 1-2)

ALX1 (FND3)

Pini et al. identify a homeodomain missense variant p.Leu165Phe (L165F) and connect it to neural crest cell apoptosis/migration defects and altered BMP2/BMP9 signaling. (pini2020alx1‐ pages 1-2)

EFNB1 (craniofrontonasal syndrome)

Pachajoa et al. report a novel heterozygous EFNB1 variant c.374A>C (p.Glu125Ala). (pachajoa2023casereportcraniofrontonasal pages 1-3)

4.3 Functional consequences (current understanding)

ALX-related FND is supported as primarily involving loss-of-function / impaired transcription factor function that perturbs neural crest biology; variants frequently affect the homeodomain, consistent with disrupted DNA binding and downstream gene regulation. (twigg2009frontorhinyadistinctive pages 2-3, kayserili2009alx4dysfunctiondisrupts pages 2-3)

EFNB1-related CFNS is mechanistically explained by mosaicism from X-inactivation leading to “cellular interference” (aberrant cell sorting and ectopic boundaries), disrupting osteogenic differentiation and calvarial development. (farlie2016frontonasaldysplasiatowards pages 4-5)

4.4 Modifier genes / epigenetics

No validated human modifier genes or disease-specific epigenetic signatures were identified in the retrieved evidence.

4.5 Chromosomal abnormalities

A surgical cohort reports an ALX1-related case with a homozygous 3.7 Mb deletion as a causal lesion for FND3. (vargel2022alxrelatedfrontonasaldysplasias pages 2-3)

5. Environmental information

No specific toxins, occupational exposures, or infectious triggers were identified in the retrieved evidence as causes of FND. The primary non-genetic factor with mechanistic experimental support in retrieved texts is ethanol exposure in zebrafish alx1 mutants (developmental teratogen context). (yoon2022zebrafishmodelsof pages 1-2)

6. Mechanism / pathophysiology

6.1 Causal chain (ALX-related FND; evidence-based)

Upstream genetic lesion (ALX1/ALX3/ALX4 variant) → neural crest developmental disruption → frontonasal mesenchyme hypoplasia/patterning defects → craniofacial midline malformations. (pini2020alx1‐ pages 1-2, iyyanar2022alx1deficientmice pages 1-2)

Key mechanistic steps supported by experiments: - Neural crest apoptosis and migration defects: Patient-derived iPSC neural crest cells homozygous for ALX1L165F show increased apoptosis and impaired migration; zebrafish lineage tracing demonstrates defective migration of anterior cranial NCC streams. (pini2020alx1‐ pages 1-2) - BMP pathway dysregulation as a mediator: Altered BMP levels in NCC-conditioned media (low BMP2, high BMP9) with rescue of migration defects by soluble BMP2 or BMP9 antagonism. (pini2020alx1‐ pages 1-2) - Patterning identity shifts in craniofacial mesenchyme (mouse): Alx1 deletion increases periocular mesenchyme apoptosis and alters regional identity (loss of Pax7; ectopic Lhx6/Lhx8), providing a developmental basis for nasal/facial clefts and ocular defects. (iyyanar2022alx1deficientmice pages 1-2, iyyanar2022alx1deficientmice pages 9-11) - Oxidative stress and ethanol interaction (zebrafish): alx genes regulate oxidative stress response; ethanol exposure increases malformation penetrance in alx1 mutants. (yoon2022zebrafishmodelsof pages 1-2)

6.2 Upstream regulators and recent developments (2024)

Nguyen et al. (Development; 2024-01; https://doi.org/10.1242/dev.202095) report that TFAP2 paralogs regulate midfacial development partly by directly and positively regulating ALX gene expression, based on bulk/single-cell RNA-seq and ChIP-seq, with cross-species evidence in mouse and zebrafish. (nguyen2024tfap2paralogsregulate pages 1-3)

6.3 Suggested ontology terms

Cell type (CL): - Cranial neural crest cell (CL term not provided in retrieved evidence; suggested mapping: “neural crest cell”)

Anatomy (UBERON): - Frontonasal process; frontonasal prominence; periocular mesenchyme; lateral nasal process; anterior neurocranium (concepts supported in mechanism papers). (farlie2016frontonasaldysplasiatowards pages 1-2, iyyanar2022alx1deficientmice pages 9-11)

Biological processes (GO; suggested based on evidence): - Neural crest cell migration - Regulation of apoptotic process - Craniofacial morphogenesis - BMP signaling pathway - Response to oxidative stress (pini2020alx1‐ pages 1-2, yoon2022zebrafishmodelsof pages 1-2)

7. Anatomical structures affected

Primary: craniofacial midline structures derived from the frontonasal process and cranial neural crest (nose, midface, frontonasal skeleton) (farlie2016frontonasaldysplasiatowards pages 1-2, pini2020alx1‐ pages 1-2)

Frequent associated structures: - Eyes/orbits (microphthalmia/anophthalmia, coloboma; especially ALX1/FND3) (vargel2022alxrelatedfrontonasaldysplasias pages 2-3, iyyanar2022alx1deficientmice pages 1-2) - Brain/CNS midline structures (e.g., corpus callosum anomalies in FND2 and in prenatal cases) (farlie2016frontonasaldysplasiatowards pages 4-5, guo2024prenataldiagnosisof pages 3-5) - Skull/calvaria (parietal bone defects/foramina; craniosynostosis in some ALX4 and EFNB1 disorders) (farlie2016frontonasaldysplasiatowards pages 4-5, pachajoa2023casereportcraniofrontonasal pages 1-3)

8. Temporal development

Onset: congenital; can be detected prenatally by ultrasound in some cases. (guo2024prenataldiagnosisof pages 1-3)
Critical periods: embryonic craniofacial development during neural crest migration and frontonasal prominence formation; model evidence suggests vulnerability to ethanol-induced oxidative stress in this developmental window. (yoon2022zebrafishmodelsof pages 1-2)

9. Inheritance and population

9.1 Epidemiology (available evidence)

Quantitative prevalence/incidence was not available in the retrieved full texts. The strongest “rarity statistic” in retrieved evidence is prenatal ascertainment: - “Only approximately 10 cases of prenatally diagnosed nonsyndromic FND have been reported in the past 30 years” (Guo 2024). (guo2024prenataldiagnosisof pages 1-3)

9.2 Inheritance patterns

ALX3/frontorhiny (FND1): autosomal recessive; homozygous affected individuals; heterozygous relatives generally unaffected in Twigg et al. (twigg2009frontorhinyadistinctive pages 2-3)
ALX1/FND3: autosomal recessive forms reported; mechanistic evidence from a missense variant family is consistent with a causal ALX1 defect affecting NCC biology. (pini2020alx1‐ pages 1-2)
ALX4/FND2: often autosomal recessive in consanguineous families (homozygous nonsense/missense); heterozygous mild phenotypes can occur. (kayserili2009alx4dysfunctiondisrupts pages 2-3, hussain2020anovelmissense pages 1-2)
EFNB1/CFNS: X-linked; paradoxically more severe in heterozygous females; mechanistically linked to mosaic cellular interference. (farlie2016frontonasaldysplasiatowards pages 4-5, pachajoa2023casereportcraniofrontonasal pages 1-3)

9.3 Population notes

Case evidence includes families/populations from multiple regions (e.g., Turkish consanguineous families with ALX4; Colombian EFNB1 case; Bangladeshi ALX4 case report), supporting broad geographic occurrence rather than a single endemic population (no founder-effect statistics were present in retrieved evidence). (kayserili2009alx4dysfunctiondisrupts pages 2-3, pachajoa2023casereportcraniofrontonasal pages 1-3, goswami2024ararehomozygous pages 1-2)

10. Diagnostics

10.1 Clinical criteria

Clinical diagnosis uses recognition of characteristic craniofacial features; a minimum of two characteristic findings is noted as diagnostic in recent prenatal review discussion. (guo2024prenataldiagnosisof pages 1-3)

10.2 Imaging

Prenatal ultrasound (including 3D ultrasound): 3D ultrasound is highlighted as useful for detecting facial and limb deformities. (guo2024prenataldiagnosisof pages 1-3)

10.3 Genetic testing strategy (as implemented in recent reports)

In a severe prenatal case, a comprehensive genetic workup included: - Karyotype analysis - Copy-number variant (CNV) analysis - Trio-WES and trio-WGS, with no de novo variants detected in the fetus in that report (guo2024prenataldiagnosisof pages 1-3)

In the prenatal nonsyndromic aggregation, genetic testing across cases was often negative (karyotype performed for all; CNV and targeted testing in subsets). (guo2024prenataldiagnosisof pages 3-5)

For postnatal Mendelian diagnosis, evidence supports targeted sequencing/panels covering: - ALX1, ALX3, ALX4 (ALX-related FND) - EFNB1 (CFNS, especially if coronal craniosynostosis and ectodermal findings are present) (vargel2022alxrelatedfrontonasaldysplasias pages 1-2, farlie2016frontonasaldysplasiatowards pages 4-5)

10.4 Differential diagnosis

The retrieved evidence explicitly notes diagnostic complexity in prenatal settings and that additional anomalies can complicate syndrome assignment; a cited example differential is amniotic band sequence when limb anomalies accompany craniofacial findings. (guo2024prenataldiagnosisof pages 6-7)

11. Outcome / prognosis

Quantitative survival/mortality statistics were not found in the retrieved evidence. Prognosis is implied to be dominated by: - Severity of craniofacial clefting and ocular malformations (ALX1/FND3 particularly severe) (vargel2022alxrelatedfrontonasaldysplasias pages 2-3, iyyanar2022alx1deficientmice pages 1-2) - Presence of CNS malformations in prenatal cases (guo2024prenataldiagnosisof pages 3-5) - Requirement for multi-stage reconstructive surgery with craniofacial teams (vargel2022alxrelatedfrontonasaldysplasias pages 5-6)

12. Treatment (current applications / real-world implementation)

No pharmacologic disease-modifying therapies were identified in the retrieved evidence; treatment is predominantly surgical and supportive.

12.1 Surgical and interventional management (evidence-based)

A large single-institution surgical cohort (89 evaluated; 13 genetically confirmed ALX-related cases) proposes genotype-informed management, including: - Facial bipartition / bipartition osteotomy for severe hypertelorism and midface alignment (vargel2022alxrelatedfrontonasaldysplasias pages 5-6, vargel2022alxrelatedfrontonasaldysplasias pages 1-2) - Fronto-orbital advancement (and distraction osteogenesis in severe cases) (vargel2022alxrelatedfrontonasaldysplasias pages 5-6) - Cleft lip/palate repair (vargel2022alxrelatedfrontonasaldysplasias pages 1-2) - Nasal reconstruction and staged craniofacial procedures (vargel2022alxrelatedfrontonasaldysplasias pages 5-6) - Eyelid coloboma repair (vargel2022alxrelatedfrontonasaldysplasias pages 1-2)

12.2 Supportive care / complication management

Reported associated issues and supportive interventions include: - Serous otitis media requiring tympanostomy tubes in some patients (vargel2022alxrelatedfrontonasaldysplasias pages 5-6)

12.3 Suggested MAXO terms (examples; based on described interventions)

Craniofacial reconstructive surgery (facial bipartition)
Fronto-orbital advancement
Cleft lip repair / cleft palate repair
Rhinoplasty / nasal reconstruction
Tympanostomy tube placement (vargel2022alxrelatedfrontonasaldysplasias pages 5-6, vargel2022alxrelatedfrontonasaldysplasias pages 1-2)

12.4 Clinical trials

No FND-specific clinical trials were identified in the retrieved ClinicalTrials-like searches (none were retrieved), consistent with the predominantly surgical management paradigm.

13. Prevention

Primary prevention is limited because most forms are Mendelian congenital malformations.

Evidence-supported prevention/mitigation concepts: - Genetic counseling for families with autosomal recessive ALX-related disease or X-linked EFNB1 disease, given the clear inheritance patterns documented in families. (twigg2009frontorhinyadistinctive pages 2-3, farlie2016frontonasaldysplasiatowards pages 4-5) - Avoidance of prenatal ethanol exposure is biologically plausible and supported by zebrafish alx1 gene–environment evidence linking ethanol to increased malformation penetrance via oxidative stress. (yoon2022zebrafishmodelsof pages 1-2)

14. Other species / natural disease

A naturally occurring “frontonasal dysplasia” phenotype has been associated with an ALX1 variant in Burmese cats, demonstrating cross-species relevance of ALX genes to frontonasal morphology (though detailed phenotype data were not extracted in the gathered evidence snippets). (farlie2016frontonasaldysplasiatowards pages 6-6)

15. Model organisms

Evidence supports the following models and what they recapitulate:

15.1 Zebrafish

alx1;alx3 double mutants develop highly penetrant cranial and ocular defects resembling human ALX1-linked FND; anterior cranial neural crest migration defects and ocular vasculature/anterior segment abnormalities are reported; oxidative stress response implicated; ethanol increases penetrance in alx1 mutants. (yoon2022zebrafishmodelsof pages 1-2)

15.2 Mouse

Alx1 deletion mice recapitulate FND-like craniofacial malformations; mechanistic findings include periocular mesenchyme apoptosis, reduced Pitx2/Lmxb1, optic stalk morphogenesis defects, and altered frontonasal mesenchyme identity (Pax7 loss; ectopic Lhx6/8). (iyyanar2022alx1deficientmice pages 1-2, iyyanar2022alx1deficientmice pages 9-11)

15.3 Human iPSC-derived neural crest (in vitro)

Patient iPSC-derived NCC demonstrate apoptosis and migration defects with ALX1L165F; BMP2/BMP9 manipulation rescues migration defects, providing a tractable human cell model for mechanism testing. (pini2020alx1‐ pages 1-2)

High-value structured summary (genes/subtypes/phenotypes)

Condition/entity	Causal gene(s)	Inheritance pattern (supported by evidence)	Representative pathogenic variants (HGVS if available)	Key distinguishing phenotypes	Key sources
Frontonasal dysplasia (overall)	Genetically heterogeneous; ALX1, ALX3, ALX4 are major ALX-related causes; EFNB1 causes the related craniofrontonasal syndrome within the broader differential	Heterogeneous: autosomal recessive ALX1/ALX3 forms; ALX4 can be recessive and in some families dominant/vertical transmission; EFNB1 disorder is X-linked (vargel2022alxrelatedfrontonasaldysplasias pages 1-2, farlie2016frontonasaldysplasiatowards pages 4-5, bertola2013verticaltransmissionof pages 5-5)	Not a single recurrent variant across all FND; examples occur in subtype rows below	Midline craniofacial malformation spectrum including true ocular hypertelorism, broad nasal root/bridge, bifid or hypoplastic nasal tip, median facial cleft, alar clefts, and widow’s peak/V-shaped hairline (farlie2016frontonasaldysplasiatowards pages 1-2, guo2024prenataldiagnosisof pages 1-3)	Vargel 2022, DOI:10.1177/10556656211019621; Farlie 2016, DOI:10.1159/000450533; Guo 2024, DOI:10.1186/s12884-024-06619-4
FND1 / frontorhiny	ALX3	Autosomal recessive; affected individuals homozygous, heterozygous relatives typically unaffected (twigg2009frontorhinyadistinctive pages 2-3, ullah2018exomesequencingrevealed pages 3-4)	c.595-2A>T; c.608A>G (p.Asn203Ser); c.502C>G (p.Leu168Val); c.604C>T (p.Gln202*) (twigg2009frontorhinyadistinctive pages 2-3, ullah2018exomesequencingrevealed pages 3-4)	Widened/long philtrum with prominent bilateral periphiltral swellings or philtral columns, bifid nasal tip, hypoplastic columella, slit-like nares/columellar pit, hypertelorism, ptosis; generally lacks parietal foramina (vargel2022alxrelatedfrontonasaldysplasias pages 1-2, vargel2022alxrelatedfrontonasaldysplasias pages 2-3, kayserili2012mildnasalmalformations pages 7-8)	Twigg 2009, DOI:10.1016/j.ajhg.2009.04.009; Ullah 2018, DOI:10.1038/s10038-017-0358-y; Vargel 2022, DOI:10.1177/10556656211019621
FND2	ALX4	Usually autosomal recessive in homozygous cases from consanguineous families; milder heterozygous phenotypes/vertical transmission also reported in some families (kayserili2009alx4dysfunctiondisrupts pages 2-3, el‐ruby2018identificationofa pages 5-5, hussain2020anovelmissense pages 1-2, bertola2013verticaltransmissionof pages 5-5)	c.652C>T (p.Arg218Trp); c.291delG (p.Gln98Serfs*83); c.793C>T; homozygous nonsense ALX4 variant reported in 2009 study but HGVS not provided in gathered evidence (hussain2020anovelmissense pages 1-2, el‐ruby2018identificationofa pages 5-5, vargel2022alxrelatedfrontonasaldysplasias pages 2-3)	Severe hypertelorism, brachycephaly, broad/depressed nasal bridge or dorsum, bifid nose, large parietal skull defects/parietal foramina, alopecia, craniosynostosis, hypogonadism/genital anomalies, brain anomalies including corpus callosum defects (vargel2022alxrelatedfrontonasaldysplasias pages 1-2, farlie2016frontonasaldysplasiatowards pages 4-5, vargel2022alxrelatedfrontonasaldysplasias pages 2-3, goswami2024ararehomozygous pages 1-2)	Kayserili 2009, DOI:10.1093/hmg/ddp391; El-Ruby 2018, DOI:10.1002/ajmg.a.38655; Hussain 2020, DOI:10.1089/gtmb.2019.0203; Goswami 2024, DOI:10.1016/j.heliyon.2024.e34929
FND3	ALX1	Autosomal recessive (vargel2022alxrelatedfrontonasaldysplasias pages 7-7, ullah2018exomesequencingrevealed pages 3-4)	c.531+1G>A; homozygous ~3.7 Mb deletion involving ALX1; p.Leu165Phe missense variant linked to defective neural crest cell development/migration (vargel2022alxrelatedfrontonasaldysplasias pages 2-3, pini2020alx1‐ pages 1-2)	Most severe ALX-related subtype: bilateral severe microphthalmia/anophthalmia, upper eyelid colobomata, bilateral facial clefts, complete cleft palate, hypoplastic alae nasi, wide nasal bridge, brachycephaly, absent brows/eyelashes, major ocular involvement (vargel2022alxrelatedfrontonasaldysplasias pages 1-2, vargel2022alxrelatedfrontonasaldysplasias pages 2-3, farlie2016frontonasaldysplasiatowards pages 1-2)	Uz 2010, DOI:10.1016/j.ajhg.2010.04.002; Pini 2020, DOI:10.15252/emmm.202012013; Vargel 2022, DOI:10.1177/10556656211019621
Craniofrontonasal syndrome	EFNB1	X-linked; paradoxically more severe in heterozygous females than hemizygous males due to cellular interference/X-inactivation mosaicism (farlie2016frontonasaldysplasiatowards pages 4-5, pachajoa2023casereportcraniofrontonasal pages 1-3)	c.374A>C (p.Glu125Ala); broader EFNB1 spectrum includes missense, nonsense, frameshift, and splice variants, many in exons 2–3/Eph-binding domain (pachajoa2023casereportcraniofrontonasal pages 1-3, 12025clinicalandmolecular pages 6-6, pachajoa2023casereportcraniofrontonasal pages 3-4)	Coronal craniosynostosis with facial asymmetry, severe hypertelorism, bifid or hypoplastic nasal tip, nail ridging/splitting, wiry/curly hair, skeletal anomalies; males often milder (farlie2016frontonasaldysplasiatowards pages 4-5, pachajoa2023casereportcraniofrontonasal pages 1-3)	Pachajoa 2023, DOI:10.3389/fgene.2022.1092301; Farlie 2016, DOI:10.1159/000450533

Table: This table summarizes the principal genetic entities relevant to frontonasal dysplasia and closely related craniofrontonasal syndrome, including causal genes, inheritance, representative variants, and distinguishing phenotypes. It is useful as a compact genotype-phenotype reference based only on the gathered evidence.

Expert synthesis / interpretation (evidence-based)

1) The strongest convergent mechanistic theme across ALX-related FND is cranial neural crest dysfunction (apoptosis, migration, and regional identity/patterning), supported across human iPSC models and mouse/zebrafish in vivo studies. (pini2020alx1‐ pages 1-2, iyyanar2022alx1deficientmice pages 1-2, yoon2022zebrafishmodelsof pages 1-2)

2) Recent developmental-genomics work strengthens the concept of an upstream TFAP2 → ALX transcriptional axis in midfacial neural crest, suggesting that some “unsolved” FND-like phenotypes (negative for ALX variants) might reflect disruptions in upstream regulators or regulatory elements affecting ALX expression rather than coding variants alone. (nguyen2024tfap2paralogsregulate pages 1-3, guo2024prenataldiagnosisof pages 6-7)

3) The 2024 prenatal literature compilation underscores that prenatal diagnosis of nonsyndromic FND remains uncommon and that a major practical barrier is phenotypic heterogeneity with often negative standard cytogenetic and exome/genome testing—highlighting ongoing needs for improved prenatal phenotype ontologies and noncoding/regulatory variant assessment. (guo2024prenataldiagnosisof pages 1-3, guo2024prenataldiagnosisof pages 3-5)

References

(guo2024prenataldiagnosisof pages 1-3): Cui-Xia Guo, Tiejuan Zhang, Ying Ma, Song Yue, and Lijuan Sun. Prenatal diagnosis of a severe form of frontonasal dysplasia with severe limb anomalies, hydrocephaly, a hypoplastic corpus callosum, and a ventricular septal defect using 3d ultrasound: a case report and literature review. BMC Pregnancy and Childbirth, Jun 2024. URL: https://doi.org/10.1186/s12884-024-06619-4, doi:10.1186/s12884-024-06619-4. This article has 7 citations and is from a peer-reviewed journal.
(farlie2016frontonasaldysplasiatowards pages 1-2): Peter G. Farlie, Naomi L. Baker, Patrick Yap, and Tiong Y. Tan. Frontonasal dysplasia: towards an understanding of molecular and developmental aetiology. Molecular Syndromology, 7:312-321, Oct 2016. URL: https://doi.org/10.1159/000450533, doi:10.1159/000450533. This article has 62 citations and is from a peer-reviewed journal.
(vargel2022alxrelatedfrontonasaldysplasias pages 1-2): Ibrahim Vargel, Halil Ibrahim Canter, Arda Kucukguven, Asim Aydin, and Figen Ozgur. Alx-related frontonasal dysplasias: clinical characteristics and surgical management. The Cleft Palate-Craniofacial Journal, 59:637-643, Jun 2022. URL: https://doi.org/10.1177/10556656211019621, doi:10.1177/10556656211019621. This article has 6 citations.
(twigg2009frontorhinyadistinctive pages 2-3): Stephen R.F. Twigg, Sarah L. Versnel, Gudrun Nürnberg, Melissa M. Lees, Meenakshi Bhat, Peter Hammond, Raoul C.M. Hennekam, A. Jeannette M. Hoogeboom, Jane A. Hurst, David Johnson, Alexis A. Robinson, Peter J. Scambler, Dianne Gerrelli, Peter Nürnberg, Irene M.J. Mathijssen, and Andrew O.M. Wilkie. Frontorhiny, a distinctive presentation of frontonasal dysplasia caused by recessive mutations in the alx3 homeobox gene. American journal of human genetics, 84 5:698-705, May 2009. URL: https://doi.org/10.1016/j.ajhg.2009.04.009, doi:10.1016/j.ajhg.2009.04.009. This article has 154 citations and is from a highest quality peer-reviewed journal.
(kayserili2009alx4dysfunctiondisrupts pages 2-3): Hulya Kayserili, Elif Uz, Carien Niessen, Ibrahim Vargel, Yasemin Alanay, Gokhan Tuncbilek, Gokhan Yigit, Oya Uyguner, Sukru Candan, Hamza Okur, Serkan Kaygin, Sevim Balci, Emin Mavili, Mehmet Alikasifoglu, Ingo Haase, Bernd Wollnik, and Nurten Ayse Akarsu. Alx4 dysfunction disrupts craniofacial and epidermal development. Human molecular genetics, 18 22:4357-66, Nov 2009. URL: https://doi.org/10.1093/hmg/ddp391, doi:10.1093/hmg/ddp391. This article has 158 citations and is from a domain leading peer-reviewed journal.
(farlie2016frontonasaldysplasiatowards pages 4-5): Peter G. Farlie, Naomi L. Baker, Patrick Yap, and Tiong Y. Tan. Frontonasal dysplasia: towards an understanding of molecular and developmental aetiology. Molecular Syndromology, 7:312-321, Oct 2016. URL: https://doi.org/10.1159/000450533, doi:10.1159/000450533. This article has 62 citations and is from a peer-reviewed journal.
(goswami2024ararehomozygous pages 1-2): Barna Goswami, Asifur Rahman, Iffat Jahan, Shahina Akter, Tanjina Akhtar Banu, Eshrar Osman, Mohammad Samir Uzzaman, Ahashan Habib, Md Shamsul Alam, Abu Saleh Mohammad Abu Obaida, Md Murshed Hasan Sarkar, and Salim Khan. A rare homozygous alx4 mutation in a bangladeshi girl with frontonasal dysplasia type-2 (fnd2). Heliyon, 10:e34929, Aug 2024. URL: https://doi.org/10.1016/j.heliyon.2024.e34929, doi:10.1016/j.heliyon.2024.e34929. This article has 2 citations.
(nguyen2024tfap2paralogsregulate pages 1-3): Timothy T. Nguyen, Jennyfer M. Mitchell, Michaela D. Kiel, Colin P. Kenny, Hong Li, Kenneth L. Jones, Robert A. Cornell, Trevor J. Williams, James T. Nichols, and Eric Van Otterloo. Tfap2 paralogs regulate midfacial development in part through a conserved alx genetic pathway. Development, Jan 2024. URL: https://doi.org/10.1242/dev.202095, doi:10.1242/dev.202095. This article has 15 citations and is from a domain leading peer-reviewed journal.
(vargel2022alxrelatedfrontonasaldysplasias pages 2-3): Ibrahim Vargel, Halil Ibrahim Canter, Arda Kucukguven, Asim Aydin, and Figen Ozgur. Alx-related frontonasal dysplasias: clinical characteristics and surgical management. The Cleft Palate-Craniofacial Journal, 59:637-643, Jun 2022. URL: https://doi.org/10.1177/10556656211019621, doi:10.1177/10556656211019621. This article has 6 citations.
(guo2024prenataldiagnosisof pages 3-5): Cui-Xia Guo, Tiejuan Zhang, Ying Ma, Song Yue, and Lijuan Sun. Prenatal diagnosis of a severe form of frontonasal dysplasia with severe limb anomalies, hydrocephaly, a hypoplastic corpus callosum, and a ventricular septal defect using 3d ultrasound: a case report and literature review. BMC Pregnancy and Childbirth, Jun 2024. URL: https://doi.org/10.1186/s12884-024-06619-4, doi:10.1186/s12884-024-06619-4. This article has 7 citations and is from a peer-reviewed journal.
(pini2020alx1‐ pages 1-2): Jonathan Pini, Janina Kueper, Yiyuan David Hu, Kenta Kawasaki, Pan Yeung, Casey Tsimbal, Baul Yoon, Nikkola Carmichael, Richard L Maas, Justin Cotney, Yevgenya Grinblat, and Eric C Liao. alx 1‐ related frontonasal dysplasia results from defective neural crest cell development and migration. EMBO Molecular Medicine, Sep 2020. URL: https://doi.org/10.15252/emmm.202012013, doi:10.15252/emmm.202012013. This article has 34 citations and is from a highest quality peer-reviewed journal.
(iyyanar2022alx1deficientmice pages 1-2): Paul P. R. Iyyanar, Zhaoming Wu, Yu Lan, Yueh-Chiang Hu, and Rulang Jiang. Alx1 deficient mice recapitulate craniofacial phenotype and reveal developmental basis of alx1-related frontonasal dysplasia. Frontiers in Cell and Developmental Biology, Jan 2022. URL: https://doi.org/10.3389/fcell.2022.777887, doi:10.3389/fcell.2022.777887. This article has 32 citations.
(yoon2022zebrafishmodelsof pages 1-2): Baul Yoon, Pan Yeung, Nicholas Santistevan, Lauren E. Bluhm, Kenta Kawasaki, Janina Kueper, Richard Dubielzig, Jennifer VanOudenhove, Justin Cotney, Eric C. Liao, and Yevgenya Grinblat. Zebrafish models of alx-linked frontonasal dysplasia reveal a role for alx1 and alx3 in the anterior segment and vasculature of the developing eye. Biology Open, May 2022. URL: https://doi.org/10.1242/bio.059189, doi:10.1242/bio.059189. This article has 6 citations and is from a peer-reviewed journal.
(pachajoa2023casereportcraniofrontonasal pages 1-3): Harry Pachajoa, Diana Marcela Vasquez-Forero, and Sebastian Giraldo-Ocampo. Case report: craniofrontonasal syndrome caused by a novel variant in the efnb1 gene in a colombian woman. Frontiers in Genetics, Jan 2023. URL: https://doi.org/10.3389/fgene.2022.1092301, doi:10.3389/fgene.2022.1092301. This article has 2 citations and is from a peer-reviewed journal.
(hussain2020anovelmissense pages 1-2): Shabir Hussain, Umm-e-Kalsoom, Irfan Ullah, Khurram Liaqat, Shoaib Nawaz, and Wasim Ahmad. A novel missense variant in thealx4gene underlies mild to severe frontonasal dysplasia in a consanguineous family. Genetic Testing and Molecular Biomarkers, 24:217-223, Apr 2020. URL: https://doi.org/10.1089/gtmb.2019.0203, doi:10.1089/gtmb.2019.0203. This article has 6 citations and is from a peer-reviewed journal.
(vargel2022alxrelatedfrontonasaldysplasias pages 5-6): Ibrahim Vargel, Halil Ibrahim Canter, Arda Kucukguven, Asim Aydin, and Figen Ozgur. Alx-related frontonasal dysplasias: clinical characteristics and surgical management. The Cleft Palate-Craniofacial Journal, 59:637-643, Jun 2022. URL: https://doi.org/10.1177/10556656211019621, doi:10.1177/10556656211019621. This article has 6 citations.
(ullah2018exomesequencingrevealed pages 3-4): Asmat Ullah, Muhammad Umair, Umm e-Kalsoom, Shaheen Shahzad, Sulman Basit, and Wasim Ahmad. Exome sequencing revealed a novel nonsense variant in alx3 gene underlying frontorhiny. Journal of Human Genetics, 63:97-100, Nov 2018. URL: https://doi.org/10.1038/s10038-017-0358-y, doi:10.1038/s10038-017-0358-y. This article has 11 citations and is from a peer-reviewed journal.
(iyyanar2022alx1deficientmice pages 9-11): Paul P. R. Iyyanar, Zhaoming Wu, Yu Lan, Yueh-Chiang Hu, and Rulang Jiang. Alx1 deficient mice recapitulate craniofacial phenotype and reveal developmental basis of alx1-related frontonasal dysplasia. Frontiers in Cell and Developmental Biology, Jan 2022. URL: https://doi.org/10.3389/fcell.2022.777887, doi:10.3389/fcell.2022.777887. This article has 32 citations.
(guo2024prenataldiagnosisof pages 6-7): Cui-Xia Guo, Tiejuan Zhang, Ying Ma, Song Yue, and Lijuan Sun. Prenatal diagnosis of a severe form of frontonasal dysplasia with severe limb anomalies, hydrocephaly, a hypoplastic corpus callosum, and a ventricular septal defect using 3d ultrasound: a case report and literature review. BMC Pregnancy and Childbirth, Jun 2024. URL: https://doi.org/10.1186/s12884-024-06619-4, doi:10.1186/s12884-024-06619-4. This article has 7 citations and is from a peer-reviewed journal.
(farlie2016frontonasaldysplasiatowards pages 6-6): Peter G. Farlie, Naomi L. Baker, Patrick Yap, and Tiong Y. Tan. Frontonasal dysplasia: towards an understanding of molecular and developmental aetiology. Molecular Syndromology, 7:312-321, Oct 2016. URL: https://doi.org/10.1159/000450533, doi:10.1159/000450533. This article has 62 citations and is from a peer-reviewed journal.
(bertola2013verticaltransmissionof pages 5-5): Débora R Bertola, Melina G. Rodrigues, Caio R.D.C. Quaio, Chong A. Kim, and Maria Rita Passos‐Bueno. Vertical transmission of a frontonasal phenotype caused by a novel alx4 mutation. American Journal of Medical Genetics Part A, 161:600-604, Mar 2013. URL: https://doi.org/10.1002/ajmg.a.35762, doi:10.1002/ajmg.a.35762. This article has 33 citations.
(kayserili2012mildnasalmalformations pages 7-8): Hülya Kayserili, U. Altunoglu, H. Ozgur, S. Basaran, and Z.O. Uyguner. Mild nasal malformations and parietal foramina caused by homozygous alx4 mutations. American Journal of Medical Genetics Part A, 158A:236-244, Jan 2012. URL: https://doi.org/10.1002/ajmg.a.34390, doi:10.1002/ajmg.a.34390. This article has 35 citations.
(el‐ruby2018identificationofa pages 5-5): Mona El‐Ruby, Alaa El‐Din Fayez, Sara H. El‐Dessouky, Mona S. Aglan, Inas Mazen, Nora Ismail, Hanan H. Afifi, Maha M. Eid, Mostafa I. Mostafa, Mennat I. Mehrez, Yasmin Khalil, Maha S. Zaki, Khaled R. Gaber, Mohamed S. Abdel‐Hamid, and Ghada M. H. Abdel‐Salam. Identification of a novel homozygous alx4 mutation in two unrelated patients with frontonasal dysplasia type‐2. American Journal of Medical Genetics Part A, 176:1190-1194, May 2018. URL: https://doi.org/10.1002/ajmg.a.38655, doi:10.1002/ajmg.a.38655. This article has 13 citations.
(vargel2022alxrelatedfrontonasaldysplasias pages 7-7): Ibrahim Vargel, Halil Ibrahim Canter, Arda Kucukguven, Asim Aydin, and Figen Ozgur. Alx-related frontonasal dysplasias: clinical characteristics and surgical management. The Cleft Palate-Craniofacial Journal, 59:637-643, Jun 2022. URL: https://doi.org/10.1177/10556656211019621, doi:10.1177/10556656211019621. This article has 6 citations.
(12025clinicalandmolecular pages 6-6): Umut Altunoglu 1, Birsen Karaman 1, Yasemin Alanay, Ferda Perçin, Zehra Oya Uyguner, and Hülya Kayserili 1. Clinical and molecular analyses in 8 new craniofrontonasal syndrome families: revisiting the mild end of the phenotypic spectrum in females. Turkish Archives of Pediatrics, 60:191-199, Mar 2025. URL: https://doi.org/10.5152/turkarchpediatr.2025.24336, doi:10.5152/turkarchpediatr.2025.24336. This article has 1 citations.
(pachajoa2023casereportcraniofrontonasal pages 3-4): Harry Pachajoa, Diana Marcela Vasquez-Forero, and Sebastian Giraldo-Ocampo. Case report: craniofrontonasal syndrome caused by a novel variant in the efnb1 gene in a colombian woman. Frontiers in Genetics, Jan 2023. URL: https://doi.org/10.3389/fgene.2022.1092301, doi:10.3389/fgene.2022.1092301. This article has 2 citations and is from a peer-reviewed journal.

Ask OpenScientist

OpenScientist Report

Inheritance

Subtypes

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Treatments

Source YAML

References & Deep Research

Deep Research

Disease Characteristics Research Template

Target Disease

Research Objectives

1. Disease Information

2. Etiology

3. Phenotypes

4. Genetic/Molecular Information

5. Environmental Information

6. Mechanism / Pathophysiology

7. Anatomical Structures Affected

8. Temporal Development

9. Inheritance and Population

10. Diagnostics

11. Outcome/Prognosis

12. Treatment

13. Prevention

14. Other Species / Natural Disease

15. Model Organisms

Citation Requirements

Output Format

Frontonasal Dysplasia (FND): Comprehensive Disease Characteristics Research Report (Mendelian)

Executive summary

1. Disease information

1.1 What is the disease?

1.2 Key identifiers

1.3 Common synonyms / alternative names

1.4 Evidence sources (patient-level vs aggregated)

2. Etiology

2.1 Disease causal factors

2.1.1 Genetic causes (major, evidence-supported)

2.1.2 Developmental mechanism as etiology (frontonasal process biology)

2.2 Risk factors

2.2.1 Genetic risk factors

2.2.2 Environmental risk factors / teratogens

2.3 Protective factors

2.4 Gene–environment interactions

3. Phenotypes

3.1 Core clinical phenotype (FND)

3.2 Diagnostic criteria (clinical definition)

3.3 Subtype-specific phenotype patterns (genotype–phenotype)

3.4 Prenatal phenotype frequencies (recent quantitative data; 2024)

3.5 Quality of life impact

4. Genetic / molecular information

4.1 Causal genes (major)

4.2 Pathogenic variants (examples with variant class)

ALX3 (frontorhiny / FND1)

ALX4 (FND2)

ALX1 (FND3)

EFNB1 (craniofrontonasal syndrome)

4.3 Functional consequences (current understanding)

4.4 Modifier genes / epigenetics

4.5 Chromosomal abnormalities

5. Environmental information

6. Mechanism / pathophysiology

6.1 Causal chain (ALX-related FND; evidence-based)

6.2 Upstream regulators and recent developments (2024)

6.3 Suggested ontology terms

7. Anatomical structures affected

8. Temporal development

9. Inheritance and population

9.1 Epidemiology (available evidence)

9.2 Inheritance patterns

9.3 Population notes

10. Diagnostics

10.1 Clinical criteria

10.2 Imaging

10.3 Genetic testing strategy (as implemented in recent reports)

10.4 Differential diagnosis